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ABSTRACT 
Objective: We have assessed the methodological quality of randomized controlled trials 
(RCTs) of interventions to prevent self-harm repetition and suicide.  
Methods: Trials were identified in two systematic reviews of RCTs of psychosocial treatments 
following a recent (within six months) episode of self-harm indexed in any of five electronic 
databases (CCDANCTR-Studies and References, CENTRAL, Medline, Embase, and 
PsycINFO) between 1 January, 1998 and 29 April, 2015.  
Results: A total of 66 trials were included, 55 in adults and 11 in children and adolescents. 
While evidence for efficacy of some approaches has grown, there were few trials from low-to-
middle income countries, little information on interventions for males, information on the 
control condition was often limited, data on suicides were often not reported, and, while trials 
have increased in size in recent years, most have included too few participants to detect 
clinically significant results.  
Conclusions: There are major limitations in many trials of interventions for individuals who 
self-harm. Improved methodology, especially with regard to study size, provision of details of 
control therapy, and evaluation of key outcomes, would enhance the evidence base for 
clinicians and service users. 
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BACKGROUND 
Self-harm [defined as intentional self-injury or self-poisoning irrespective of type of motivation 
or degree of suicidal intent; (Hawton, Zahl, & Weatherall, 2003)] represents a significant public 
health burden worldwide (Haagsma et al., 2016). The term self-harm as used in the United 
Kingdom (UK) and several other countries includes behavior that in the United States of 
America (USA) would be categorized as non-suicidal self-injury (NSSI) and suicidal behavior 
disorder (attempted suicide), but also non-suicidal (as well as suicidal) self-poisoning. Self-
harm, and particularly self-poisoning, is an extremely common reason for presentation to 
healthcare facilities. In the UK alone, for example, there are now more than 200,000 hospital 
presentations for self-harm each year (Hawton et al., 2007). Self-harm is associated with 
numerous adverse outcomes. For example, between 16.3% (Carroll, Metcalfe, & Gunnell, 2014) 
and 30% (Perry et al., 2012) of those who present to hospital for self-harm will re-present to 
hospital following a repeat episode within one year. There will also be further episodes of self-
harm which do not result in hospital representation (Guthrie et al., 2001). The risk of suicide is 
also elevated; over a one year period following an episode of self-harm between 1.0% 
(Beckman et al., 2016) and 1.6% (Carroll et al., 2014) of those presenting to hospital will die 
by suicide.  
 
Given the prevalence of self-harm, the frequency with which it is repeated, and its association 
with completed suicide it is important that effective treatment interventions are developed and 
rigorously evaluated for their effectiveness. This has led	in recent decades to a proliferation of 
therapeutic interventions to reduce self-harm repetition and suicide. A Cochrane Collaboration 
systematic review and meta-analysis, published in 1998, for example, identified 19 randomized 
controlled trials (RCTs) of psychosocial interventions to reduce repetition of self-harm in 
adults, and only one for children and adolescents specifically (Hawton et al., 1998), whereas a 
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recent update of this review identified 66 RCTs of psychosocial interventions; 55 for adults 
and 11 for children and adolescents (Hawton et al., 2016b; Hawton, Witt, Taylor Salisbury, 
Arensman, Gunnell, Townsend, et al., 2015). 
 
Emerging evidence from meta-analysis of these RCTs suggests cognitive-behavioral therapy 
(CBT) based psychotherapy shows promise in reducing the proportion of adults repeating self-
harm and that dialectical behavior therapy may reduce frequency of repetition of self-harm in 
both adults and adolescents (Hawton et al., 2016a, 2016b). However, there remains limited 
evidence about the effectiveness of other psychosocial interventions for self-harm repetition 
(Hetrick, Robinson, Spittal, & Carter, 2016). This is partly because most RCTs are 
underpowered to detect clinically significant effects (Arensman et al., 2001).  
 
We previously undertook a review of the methodological quality of randomized controlled 
trials of psychosocial and pharmacological interventions for the prevention of self-harm 
repetition, finding that, in general, most trials included too few participants to detect clinically 
important differences in rates of repeated self-harm (Arensman et al., 2001). We also found 
that information on the method of randomization, content of the intervention and control arms, 
and information on the representativeness of patients in these RCTs was typically lacking 
(Arensman et al., 2001). We therefore recommended that investigators should include power 
calculations to justify their sample size, that specific subgroups of patients, in particular those 
engaging in self-cutting or with alcohol and other drug use comorbidity, should be included to 
provide greater sample representativeness, and that authors should provide more details on the 
experimental intervention and control conditions (Arensman et al., 2001). 
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We have investigated the methodological quality of RCTs of psychosocial interventions for 
people who self-harm based on our recent update of the treatment literature on the effectiveness 
of psychosocial interventions for self-harm in adults and children and adolescents (Hawton et 
al., 2016a, 2016b). The aim of the current study was to provide updated guidance for 
investigators conducting trials in this area. 
 
 
METHODS 
Search strategy 
We searched for randomized controlled trials (RCTs) of psychosocial treatments following a 
recent (within six months) episode of SH indexed in any of five electronic databases 
(CCDANCTR-Studies and References, CENTRAL, Medline, Embase, and PsycINFO) 
between 1 January, 1998 and 29 April, 2015 using the electronic search strategy outlined in 
Appendix 1. Further hand searches were made of the reference lists of 44 major review papers, 
ten English language specialist suicidology and more general psychiatric journal. We also 
contacted researchers active in the field to identify unpublished literature. 
 
Inclusion Criteria 
Trials were eligible for inclusion provided they met the following criteria: (1) used random 
allocation to assign participants to the intervention and control groups; (2) all participants had 
engaged in self-harm no more than six months prior to randomization; and (3) the trial 
evaluated the effectiveness of any psychosocial therapy relative to treatment as usual (TAU), 
enhanced usual care (EUC), treatment by expert, or other standard forms of psychotherapy. 
Non-English language trials were eligible for inclusion and were translated by native speakers.  
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Trials were screened independently for inclusion by KW and one of either TTS, EA, DG, PH, 
ET, or KvH. Disagreements were resolved following discussion with KH. Where insufficient 
information was recorded in the study report to determine eligibility, study authors were 
contacted to provide additional clarification. 
 
Apprising methodological quality 
Given the focus of this paper, we rated the quality of the included studies with regards to our 
previous recommendations for improving the quality of RCTs of interventions for self-harm 
(Arensman et al., 2001). Specifically, KW and one of TTS, EA, DG, PH, ET, and KvH rated 
each included trial with regards to: (1) how representative the sample was of people who 
present to clinical services following self-harm; (2) clear definition of the intervention, 
including use of clearly specified and manualized interventions; (3) clear definition of the 
treatment(s) received by participants allocated to the control condition; (4) use of standardized 
outcome measures both for the primary outcome measure as well as any secondary outcomes 
reported; (5) whether hypothesized mechanisms of change were investigated, and; (6) 
adequacy of the sample size and use of power calculations to justify the sample size.)  
 
Risk of bias assessment 
For each study, we also assessed risk of bias using the approach favored by the Cochrane 
Collaboration (Higgins, Deeks, & Altman, 2008). Specifically, this tool assesses bias according 
to seven domains, including: (7) adequacy of the random sequence generation; (8) allocation 
concealment; (9) blinding of participants, clinical personnel and outcome assessors; (10) 
incomplete data bias as well as the adequacy of information on the proportion of participants 
who withdrew from the trial together with reasons for withdrawing; (11) selective outcome 
reporting bias, and; (12) other biases including details on the use of intention-to-treat analyses 
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for all measured outcomes. Each study was rated as at high, unclear, or low risk of bias across 
each of these seven domains.  
 
RESULTS 
The systematic search outlined in Appendix 1 retrieved a total of 23,830 citations. An 
additional 10 trials ongoing at the time of the systematic search were identified through hand 
searching. This figure was reduced to 16,799 following de-duplication. A total of 16,538 were 
excluded following screening, whilst a further 245 were excluded after reviewing the full text, 
including seven trials were excluded from the present review as they evaluated the 
effectiveness of a pharmacological intervention (Hawton, Witt, Taylor Salisbury, Arensman, 
Gunnell, Hazell, et al., 2015).  
 
A total of 66 independent RCTs were therefore included in the present article, comprising 55 
trials of psychosocial interventions for self-harm in adults (aged 18 years of age and older) and 
11 in children and adolescents (up to 18 years of age) (Figure 1). 
 
Study characteristics 
Full methodological details of these 66 trials are provided in Table 1. Briefly, the included 
trials comprised a total of 18,256 participants (17,117 in trials in adults and 1,139 in trials of 
children and adolescents). All participants had engaged in at least one episode of self-harm in 
the six months prior to randomization.  
 
The largest number of trials had been conducted in the United Kingdom (UK; 23 trials; 34.9%), 
followed by the United States of America (USA; 13 trials; 19.7%). Fewer studies were 
conducted in New Zealand (5 trials; 7.6%), Australia (3 trials; 4.6), Canada (2 trials; 3.0%), 
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Denmark (2 trials; 3.0%), France (2 trials; 3.0%), Germany (2 trials; 3.0%), The Netherlands 
(2 trials; 3.0%), and the Republic of Ireland (2 trials; 3.0%). One trial was conducted in each 
of the following countries: Belgium, China, Finland, the Islamic Republic of Iran, Japan, 
Norway, Pakistan, Sri Lanka, and Sweden. One study was a multicenter study set in a number 
of different countries. 
 
Study representativeness 
Since the publication of our original commentary in 2001 (Arensman et al., 2001), an 
increasing number of trials have been conducted in low-to-middle income countries, including: 
Brazil, China, India, the Islamic Republic of Iran, Pakistan, and Sri Lanka. However, in line 
with previous research (Gholamrezaei, De Stefano, & Heath, 2015), we found that most trials 
to date, including more recent ones, have been conducted in high income Western countries; 
particularly the UK and USA. 
 
Sample representativeness 
In all trials at least one exclusion criterion was specified (Table 1). Age was the commonest 
reason for participant exclusion, reported in 55 (83.3%) trials, followed by intellectual 
disability and/or diagnosis of organic cognitive disorders (38 trials; 57.6%), residing outside 
of the study catchment area and/or homelessness (29 trials; 43.9%), and insufficient language 
ability (19 trials; 28.8%). 
 
A number of trials also excluded potential participants on the basis of a diagnosis for any major 
mental illness (35 trials; 53.0%). Most commonly, this was for a diagnosis of psychosis and/or 
psychotic symptoms (35 trials; 53.0%), followed by bipolar disorder (12 trials; 18.2%). 
Potential participants with alcohol and other drug dependence and/or intoxication were also 
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excluded from a number of these trials (21 trials; 31.8%). In several trials participants were 
also excluded because they were currently receiving or had been referred for psychiatric 
treatment (24 trials; 36.7 %), including where treatment had been legally mandated (2 trials; 
3.0%).  
 
With regards to gender, males were specifically excluded from six trials whilst, in a seventh, 
although males were eligible for participation, no males were ultimately included (Table 1). 
Moreover, in the remaining 52 trials where information was provided on gender, in all but one 
over one-half of participants were female (range 48.5% to 94.1%; Table 1). We found no 
evidence of a significant increase in the proportion of male participants included in these trials 
by year of publication (β=-0.34, se=0.21, p=0.12; Appendix 2).  
 
Types of intervention conditions 
The trials included in this review were characterized by a diversity of interventions (Table 1). 
For adults, the most frequently evaluated intervention (18 trials; 32.7%) was cognitive-
behavioral therapy (CBT). There were five trials of dialectical behavior therapy (DBT), four 
trials of case management, four trials of postcards, three trials of telephone contact, two each 
of ‘green’ (emergency) cards, emotion-regulation skills training, intensive outpatient follow-
up, mixed multimodal interventions, and treatment adherence enhancement approaches. There 
was one trial each of a brief alcohol-related intervention, behavior therapy, brief information 
and support, general hospital admission, general practitioner letters, home-based problem-
solving therapy, mentalization, mobile telephone-based psychotherapy, interpersonal problem-
solving skills training, intensive inpatient treatment and aftercare and prolonged, long-term 
aftercare. 
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For children and adolescents, there were three trials evaluating the effectiveness of group-based 
psychotherapy, two trials of DBT adapted for adolescents (DBT-A), and one trial each of a 
CBT-based approach, ‘green’ (emergency) cards, home-based family therapy, mentalization, 
therapeutic assessment, and treatment adherence enhancement approaches (Table 1). 
 
Types of control conditions 
The experimental interventions were compared against a diversity of control conditions (Table 
1). Most trials (52 trials; 78.9%) compared the intervention to treatment as usual (TAU). The 
remaining 14 trials compared the intervention to either a different form of active psychotherapy 
(10 trials; 15.1%), enhanced usual care (two trials; 3.0%), waitlist (one trial; 1.5%), or no 
treatment (one trial; 1.5%). 
 
However, although in most trials (53 trials; 80.3%) some information was provided on the 
treatment(s) that were available to control participants, information was provided on the 
therapies actually received by these participants in only six trials (9.1%). Elsewhere we have 
shown previously that effects in favor of CBT-based psychotherapy vary by quality of TAU 
and TAU content (Witt et al., 2018). For this reason, data on TAU content and amount received 
should wherever possible be included in future trials in this area. 
 
Outcomes related to suicidal thoughts and behavior 
Data on the primary outcome measure, repetition of self-harm, were reported for all but one of 
the included trials (65 trials; 98.5%; Table 1). Most commonly, information about repetition of 
self-harm was obtained through self-report only (with or without the use of a standardized 
interview schedule) (27 trials; 41.5%), followed by hospital and/or medical records (18 trials; 
27.7%). This information was less commonly obtained from collateral informant and/or 
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hospital and/or medical records supplemented by self-reported information (13 trials; 20.0%) 
and, in single trials, through collateral informant report only or using mixed methods, namely, 
self-reported information at the post-intervention assessment and hospital records at follow-up. 
No information was provided on how the primary outcome measure was ascertained in four 
(6.1%) trials. 
 
Information on suicide deaths was recorded for the majority of trials (53 trials; 78.8%; Table 
1); although we as reviewers often had to request these data from the study authors. In a few 
studies suicides were ascertained from official sources, including mortality data or Coroner’s 
records (14 trials; 26.4%), collateral informant report only (five trials; 9.4%), or collateral 
informant report supplemented by data from official sources (four trials; 7.5%). In general, 
however, no information was provided on how suicides were ascertained (30 trials; 56.7%).  
 
Data on suicidal ideation were reported in 27 trials (40.9%; Table 1). Most commonly this was 
assessed using the self-report Beck Scale for Suicidal Ideation [BSSI; (Beck, Kovacs, & 
Weissman, 1979); 15 trials; 55.6%], followed by the Suicidal Ideation Questionnaire [SIQ; 
(Reynolds, 1988); six trials; 22.2%], the Suicidal Behaviors Questionnaire [SBQ; (Linehan, 
1981); two trials; 7.4%], the Suicidal Cognition Scale [SCS; (Rudd, Joiner, & Rajab, 2001); 
one trial; 3.7%], the Schotte Scale for Suicidal Ideators [SSI; (Schotte & Clum, 1982); one trial; 
3.7%], from an idiosyncratic scale (one trial; 3.7%), and from self-report (one trial; 3.7%).  
 
Outcomes related to other measures 
Data on other non-suicidal secondary outcomes were also reported in a number of trials (Table 
1). In line with the NICE guidelines on the short-term assessment of self-harm (National 
Institute for Clinical Excellence 2004), many trials reported data on depression (37 trials; 
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56.1%), hopelessness (19 trials; 28.8%) and, to a lesser extent, problem-solving ability (16 
trials; 24.2%). Mostly, this was using self-reported scales such as the Beck Depression 
Inventory [BDI; (Beck, Ward, Mendelsohn, Mock, & Erbaugh, 1961)], the Beck Hopelessness 
Scale [BHS; (Beck & Steer, 1988)], and various self-report scales for problem solving. 
 
Given the role of anxiety in the etiology of self-harm (Hawton, Saunders, Topiwala, & Haw, 
2013) data on anxiety were also reported in 17 trials (25.7%). However, despite recent work 
implicating alcohol as an important proximal risk factor for suicidal behavior (Borges, Bagge, 
Cherpitel, & Conner, 2017), only six trials (9.1%) evaluated the effect of treatment for self-
harm on alcohol and/or drug use.  
 
Mechanisms of change 
Few trials (3 trials; 4.5%) explicitly included data on hypothesized mechanisms of change. In 
two trials of emotion-focused regulation training, for example, the authors hypothesized that 
the intervention would improve emotion regulation and experiential avoidance which, in turn, 
would lead to a reduction in repetitive self-harming behavior (Gratz & Gunderson, 2006; Gratz, 
Tull, & Levy, 2013). In a separate report the authors found that reductions in emotion regulation 
indirectly led to reductions in self-harm through their effect on borderline personality disorder-
related cognition and affective functioning, suggesting that the ability to regulate emotion is an 
important treatment target for women with borderline personality disorder who engage in 
frequent, repeated self-harm (Gratz, Bardeen, Levy, Dixon-Gordon, & Tull, 2015).  
 
In a study of mentalization-based therapy for adolescents (MBT-A), the authors not only 
included measures of mentalization ability and avoidance, which they hypothesized would be 
related to mechanisms of change (Rossouw & Fonagy, 2012), but also used mediation analyses 
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to determine whether changes in these outcomes were related to reductions in self-harming 
behavior. These authors found that once improvements in these measures were statistically 
controlled, the effect of MBT-A on repetition of self-harm at the post-intervention assessment 
was no longer significant, suggesting that the ability to mentalize is an appropriate treatment 
target for the prevention of self-harming behavior in this age group.  
 
In some other trials, variables which could be related to such mechanisms were assessed but 
without explicit mention that they were hypothesized to be mechanisms of change. For example, 
in a number of trials of CBT-based psychotherapy, effects of the intervention on problem-
solving ability were also assessed. In two other trials of problem-solving based approaches, the 
authors also reported information on whether the intervention actually produced changes in 
ability to solve interpersonal or other problems. A number of trials of DBT also included 
information on whether the intervention led to an improved ability to tolerate emotional arousal.   
 
Selective outcome reporting 
Selective outcome reporting occurs when outcomes within an RCT are selectively reported on 
the basis of their significance (Dwan, Gamble, Williamson, & Kirkham, 2013). To investigate 
this, we searched international trial registries to obtain the study protocols for all trials 
published subsequent to the International Committee of Medical Journal Editors’ (ICMJE) 
mandatory trial registration guidelines in 2005 (De Angelis et al., 2004). Of the 34 trials 
published after 2005, just under one-half (15 trials; 44.1%) had been registered with an 
international trial registry. Just over half of the registered trials had been prospectively 
registered. However, for six (40%) they had been registered retrospectively after the trial had 
been completed. The clinical trial registry record was no longer available for one trial (Ougrin 
et al., 2011). For one further trial, additional information on the intervention was available 
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online; however, details on participant inclusion and exclusion criteria and details on the 
primary and secondary outcomes to be assessed were not available (Fleischmann et al., 2008). 
 
Sample size and power analysis 
Although the sample size for included trials has increased over time (β=23.6, se=11.9, p=0.05; 
Figure 2), most trials are still underpowered to detect significant effects for self-harm repetition 
and suicide. Using rates of self-harm and suicide for cognitive behavioral-based therapy in 
adults, the approach we found to be associated with the greatest reduction in self-harm 
repetition and suicide in our recent Cochrane review (Hawton et al., 2016b), we estimate that 
a minimum of 1,862 participants would be needed in each trial arm to detect a significant effect 
for repetition of self-harm with 80% power at the conventional p=0.05 level (Table 2). For 
suicide, moreover, a minimum of 8,757 participants would be required in each trial arm to 
detect a significant treatment effect (Table 2).  
 
Adequacy of random sequence generation 
We found that for most trials (49 trials; 74.2%) the random sequence generation was adequate. 
We did not find that outcome estimates were exaggerated in trials with inadequate or unclear 
random sequence generation as compared to those with adequate sequence generation. For 
CBT-based interventions in adults, for example, adequacy of the random sequence generation 
made no material difference to overall findings regarding the intervention for self-harm 
repetition at the final follow-up assessment, although only two such trials were rated as having 
inadequate/unclear random sequence generation (Inadequate/unclear random sequence 
generation: OR 0.63, 95% CI 0.27 to 1.49, 2 trials, p=0.29, I2=0.0%; Adequate random 
sequence generation: OR 0.68, 95% CI 0.52 to 0.89, 15 trials, p=0.005, I2=23.0%; Test for 
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subgroup differences: χ2=0.03, df=1, p=0.87). For all other categories of intervention there 
were too few included studies to meaningfully undertake such analyses. 
 
Adequacy of allocation concealment 
For the majority of trials (38 trials; 57.6%), allocation concealment was adequate, having been 
conducted using opaque, sealed envelopes (16 trials), by an offsite researcher (10 trials), or a 
third-party researcher working independently of the research team (10 trials). In the two 
remaining trials, correspondence with study authors indicated that allocation had been 
adequately concealed. 
 
We did not find that intervention estimates were exaggerated in trials with inadequate or 
unclear allocation concealment. For CBT-based interventions in adults, for example, adequacy 
of the allocation concealment procedure made no material difference to overall findings 
regarding the intervention for self-harm repetition (Test for subgroup differences: χ2=2.35, 
df=1, p=0.12; Figure 3). Similarly, for suicide, there was no evidence to suggest that trials with 
inadequate or unclear allocation concealment were associated with exaggerated treatment 
effects, although there were only seven trials in which the sequence generation procedure was 
either inadequate or unclear (Inadequate/unclear allocation concealment: OR 0.81, 95% CI 
0.23 to 2.88, 7 trials, p=0.75, I2=0.0%; Adequate allocation concealment: OR 0.57, 95% CI 
0.19 to 1.69, 8 trials, p=0.31, I2=0.0%; Test for subgroup differences: χ2=0.17, df=1, p=0.68). 
For all other categories of intervention, there were too few included studies to meaningfully 
undertake these analyses. 
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Blinding 
Adequately blinding participants, clinical personnel, and outcome assessors to treatment 
allocation minimizes the role of performance and detection bias as neither party is then likely 
to provide biased assessments as to the effectiveness of the intervention. Psychosocial 
treatment trials present unique challenges to blinding, however, as it is generally not possible 
to blind participants to the treatment they are actively receiving, or clinical personnel to the 
treatment they are delivering (Shean, 2014). As a consequence, participant and clinical 
personnel blinding could not convincingly be achieved in any of the included trials.  
 
Perhaps most surprisingly, in well under one-half of all the trials (28 trials; 42.4%) outcome 
assessors were either not blind to treatment allocation or there was insufficient information to 
confirm whether outcome assessors were blind. Whilst there was some suggestion that outcome 
estimates for repetition of self-harm may have been greater in trials with inadequate or unclear 
outcome assessor blinding, this was not significant for CBT-based trials for either repetition of 
self-harm at the final follow-up assessment (χ2=3.61, df=1, p=0.06; Figure 4) or for suicide 
(χ2=2.17, df=1, p=0.14; Figure 5). For all other categories of intervention, there were too few 
included studies to meaningfully undertake these analyses. 
 
Zelen’s post-consent design 
Four trials (6.1%) included in this review used Zelen’s post-consent randomization design 
(Carter, Clover, Whyte, Dawson, & D’este, 2005; Hatcher, Coupe, Wikirwhi, Durie, & Pillai, 
2016; Hatcher et al., 2015; Hatcher, Sharon, Parag, & Collins, 2011), in which eligible 
participants are both identified and randomly allocated to the intervention or control group 
prior to seeking their consent to take part in the trial. Allocation status is then revealed to 
participants, who can then either consent to participate, decline, or consent to participate only 
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if they can change groups (Adamson, Cockayne, Puffer, & Torgerson, 2006). In three of these 
trials, participants who refused to provide consent following treatment allocation were 
excluded from further analysis for all non-suicidal secondary outcome measures (Hatcher et 
al., 2016; Hatcher et al., 2015; Hatcher et al., 2011).  
 
 
DISCUSSION 
Recent years have seen a substantial increase in the number of RCTs of psychosocial treatments 
for adults who self-harm. Thus the number of trials has nearly trebled as of 29 April, 2015 since 
we previously reviewed trial methodology (Arensman et al., 2001). In children and adolescents, 
however, the number of trials remains relatively small, especially given the extent of self-harm 
in this population (Hawton, Saunders, & O'Connor, 2012), with one trial in our earlier review 
and just 11 in the current review.  
 
There has been a notable increase in trials from low-to-middle income countries. However, 
guidance on treatments for self-harm is still dominated by research from high income countries, 
particularly the USA and UK. Although relatively few studies have investigated characteristics 
of persons who engage in self-harm in non-Western settings (Spears, Montgomery, Gunnell, 
& Araya, 2014), there would appear to be important differences both in the methods of self-
harm used as well as the characteristics of those who engage in self-harm between lower-to-
middle income countries as compared to higher-income countries (Gholamrezaei et al., 2015). 
Opportunities for intervention are also more limited in lower-to-middle income countries. 
Possible reasons include the fact that fewer persons in low-to-middle income countries have a 
history of repeated, non-fatal episodes of self-harm, perhaps as a consequence of ready 
availability of highly lethal means (Mohamed et al., 2011), and that resource limitations mean 
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that availability of mental health professionals trained to deliver complex multi-component and 
prolonged psychosocial interventions is very limited (Benson & Shakya, 2008). 
 
The majority of participants in these trials have been female, reflecting the general 
characteristics of self-harm patients attending hospital-based services (Arensman, Griffin, & 
Corcoran, 2016; Geulayov et al., 2016). However, there appears to have been little effort to 
develop and evaluate interventions specifically focused on males. This is surprising, especially 
given the greater risk of suicide following self-harm in males than females (Carroll et al., 2014; 
Hawton, Bergen, et al., 2015). Clinically important subgroups of self-harm patients were also 
excluded from a number of these trials, including those with a diagnosis of a major mental 
illness (especially psychosis) and those with alcohol and/or other drug dependence. There were 
also no identified trials of participants older than 65 years at randomization, despite increasing 
risks of suicide in older age groups, particularly in males. 
 
We found that in trials where an intervention was compared with TAU, while the potential 
range of interventions available in the TAU condition was often indicated, there was rarely any 
record of the treatments actually received and by how many patients. In future trials where 
TAU is used as a control treatment condition we suggest that not only should the potential 
types of interventions in this condition be pre-specified, but the actual treatments received by 
patients should, if possible, be recorded. We acknowledge that specific information on the 
treatment received by participants randomized to the TAU arm may have to be excluded from 
publications owing to space limitations. For this reason, we would recommend RCTs of 
psychosocial interventions for self-harm should consider submitting this information as 
supplementary documents, as was recently done in a trial of DBT (Priebe et al., 2012). 
 
19	
	
The main outcome measures in the trials in our reviews were related to repetition of self-harm.  
These were assessed in a variety of ways, with some studies relying on self-report, which may 
have led to the identification of more episodes, especially those not resulting in presentation to 
clinical facilities (Guthrie et al., 2001). Other trials relied on hospital and/or medical records, 
which will largely identify hospital-presenting episodes only. We would therefore suggest that 
a combination of both is ideal. We would also suggest future trials in this area report data on 
frequency of repetition of self-harm. 
 
Given the strong association between self-harm and future suicide (Carroll et al., 2014; Hawton, 
Bergen, et al., 2015), it was surprising how infrequently deaths by suicide (including where 
there were no deaths), were reported, especially when requests to authors revealed that this 
information was available. However, whilst the majority of coronial investigations are closed 
within a year and a half from the date of death, we would acknowledge that at least a third of 
suicide cases remain open two years later, and a few of these remain open four years later based 
on Australian data (Studdert, Walker, Kemp, & Sutherland, 2016). We would therefore 
strongly recommend that deaths from any cause should be reported in addition to those 
attributable to suicide specifically, given the well-recognized misclassification of deaths likely 
to have been due to suicide (Gunnell et al., 2013), particularly suicides involving self-poisoning 
(Bohnert et al., 2013). To date, however, only three trials included such information 
(Fleischmann et al., 2008; Kawanishi et al., 2014; Morthorst, Krogh, Erlangsen, Alberdi, & 
Nordentoft, 2012). 
 
There is also the question of what outcomes should be assessed in trials of therapies for self-
harm patients and at what time points. Clearly this will depend partly on the characteristics of 
the patient population.  Also, consideration must be paid to restricting the number of patient-
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rated outcomes to a level that will not discourage their participation.  However, where possible, 
we suggest that the following factors should be considered for inclusion in trials in this field. 
Depression is one, given the strong links with suicidal behavior. However, with increasing 
recognition of the contributory role of anxiety in the etiology of self-harm (Hawton et al., 2013), 
we suggest that this is another important factor that should be considered for inclusion. Finally, 
because of the key mediating roles of hopelessness, suicidal ideation, and problem-solving 
(Thompson, Mazza, Herting, Randell, & Eggert, 2005), consideration should also be given to 
inclusion of measures of these outcomes.   
 
There may also be other outcomes which participants would view as being particularly 
important; investigating what these outcomes might be, and ensuring they are assessed in future 
trials in this area, is essential to ensure treatments are pertinent to this patient group (Owens, 
2010). Qualitative evaluations of future interventions will also help to generate insight into 
how the intervention process is perceived by participants themselves; and may also help to 
improve participation and adherence rates (Whitehead, Crowe, Bugge, & Coppell, 2016). 
 
One potential component of trials that is often neglected is assessment of likely mediators of 
treatment effect. However, it can reasonably be argued that the key initial aim in conducting 
trials should be to assess whether a treatment is effective, and then if it is, to investigate 
mediating factors, including through treatment dismantling procedures. 
 
In our previous paper on methodological issues in trials of interventions for self-harm patients 
we highlighted the fact that all trials were too small to allow detection of differences between 
treatment conditions in terms of repetition of self-harm (Arensman et al., 2001). While we have 
shown that the size of trial has increased somewhat in recent years, most trials are still 
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underpowered. This is likely to represent a waste of resources since the results will not usually 
generate information that can inform clinical services as to the best options for treatment. 
Larger trials are therefore required to demonstrate whether interventions are effective 
(Ioannidis, 2005). To achieve the size of trials necessary to generate reliable evidence 
multicenter studies will usually be required to allow access to sufficiently large populations of 
patients. Multicenter trials, such as the World Health Organization’s SUPRE-MISS trial 
(Fleischmann et al., 2008) and the Saving and Empowering Lives in Europe (SEYLE) Project 
(Wasserman et al., 2010). These types of trial can also provide access to diverse populations 
thereby improving the representativeness of trial participants and hence the generalizability of 
the results. However, it is recognized that trials of sufficient size to detect robust effects on 
suicide are probably not feasible. 
 
Zelen’s post-consent design was used in some recent trials, but, unlike in Zelen’s original 
concept, data on participants who subsequently refused consent to participate were excluded 
from secondary analyses. This particularly affected non-suicidal outcome measures which 
mainly relied on self-reported information. Zelen originally envisaged keeping participants’ 
data in the group to which they were randomized (Richter & Dewey, 2014). However, without 
participant consent, this does not seem feasible. The use of this trial design therefore presents 
some problems for the interpretation of results from trials. 
 
In none of the trials we reviewed were participants blind to the treatment condition to which 
they had been allocated, but in reality this is virtually impossible in trials of psychosocial 
interventions. This limitation similarly applied to the clinicians delivering treatment. As a result, 
the quality of psychosocial trials for self-harm are typically downgraded, relative to 
pharmacological trials, when entered into reviews and meta-analyses, such as those conducted 
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for the Cochrane Collaboration (Higgins & Altman, 2008). This downgrading, in turn, implies 
that these trials indicate poorer quality evidence. We suggest that in future separate rating 
measures related to blinding should be developed and applied to trials of psychosocial 
interventions to avoid giving the impression that the quality of evidence for psychosocial 
interventions is of a poorer methodological quality relative to trials for pharmacological 
interventions. 
 
In most trials that we have reviewed assessments have been conducted at certain time points 
(e.g. end of therapy and at follow up).  With the advent of successful electronic methods of 
assessing changes in mood and other psychological parameters these might be incorporated in 
future trials (Miklowitz et al., 2012). These technologies have the advantage that they can be 
used to assess progress at relatively short time-intervals (e.g., weekly), thereby providing an 
analogue for real-time assessments through, for example, the use of ecological momentary 
assessment.  
 
Finally, the end date of the systematic search which informed this paper is 29 April, 2015. 
Whilst several important trials in the field have been published in the interim, [e.g., (Asarnow, 
Hughes, Babeva, & Sugar, 2017; Cottrell et al., 2018; Furuno et al., 2018; McMain, Guimond, 
Barnhart, Habinski, & Streiner, 2017)], we would note that these newer trials are characterized 
by the same limitations in sample representativeness, outcome measurement, particularly in 
relation to the inclusion of data on hypothesized mechanisms of action, and a lack participant 
involvement in the design and evaluation of the intervention. 
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CONCLUSIONS 
Since we published our previous review of methodology of trials of therapeutic interventions 
for self-harm patients the number of trials in the field has grown substantially, and there has 
been some increase in their geographical spread worldwide. The size of trials has also increased 
somewhat. However, most trials are subject to considerable and often crucial methodological 
limitations. We hope that this report will assist those who are planning future trials in this field 
so that the results of investigations can provide greater guidance for clinicians and others 
responsible for planning clinical services, together with service users, about what treatments 
are likely to be most effective.  
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FIGURES & TABLES 
 
Figure 1. PRISMA flow diagram of included and excluded studies for this version of the review. 
 
Figure 2. Bubble plot of sample sizes in 66 trials of psychosocial therapies for self-harm in adults and 
children and adolescents by year of publication. 
 
Figure 3. Effect of cognitive behavioral-based psychotherapy versus treatment as usual for repetition 
of self-harm at the final follow-up assessment subgrouped according to adequacy of the allocation 
concealment procedure used. 
 
Figure 4. Effect of cognitive behavioral-based psychotherapy versus treatment as usual for repetition 
of self-harm at the final follow-up assessment subgrouped according to adequacy of the procedure used 
to blind outcome assessors used. 
 
 
Figure 5. Effect of cognitive behavioral-based psychotherapy versus treatment as usual for suicides at 
the final follow-up assessment subgrouped according to adequacy of the procedure used to blind 
outcome assessors used. 
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Table 1. Methodological characteristics and risk of bias for the 66 studies included in this version of the review. 
 
Study and  
Year of 
Publication 
Country 
N Age 
(SD) 
Female 
(%) Participant Source Exclusion Criteria 
Intervention and Control 
Conditions Outcome Ascertainment Risk of Bias INV CTL 
ADULTS 
 
          
Allard  
(1992) 
Canada 76 74  55.3 Patients presenting to 
hospital following a 
suicide attempt. 
• Currently receiving 
treatment through another 
service; 
• Intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent;  
• Presence of a physical 
illness and/or disability that 
would preclude attendance 
at follow-up appointments; 
and 
• Residing outside catchment 
area and/or homelessness; 
• Violence risk. 
Intensive outpatient 
therapy: comprising a 
schedule of visits including 
at least one home visit. 
Either written and/or 
telephone reminders were 
sent to participants in the 
case of missed appointments. 
TAU: continuing treatment 
by the participants’ regular 
psychiatrist within the 
hospital. Content of this 
therapy not specified. 
Repetition of SH: self-
report supplemented by 
collateral informant report 
and/or hospital records. 
Suicide: collateral informant 
report supplemented by 
Coroner’s records. 
Treatment use: hospital 
records. 
Unclear if random sequence 
was adequately generated. 
Nature of the trial suggests 
participants and clinical 
personnel not blind to 
treatment allocation. Unclear 
if outcome assessors blind to 
treatment allocation. Data on 
24 participants lost to follow-
up not reported and reasons 
for participant attrition not 
provided. 
Bateman 
(2009) 
UK 71 63  88.4 Consecutive referrals to 
one of two community 
outpatient psychiatric 
facilities, one of which 
specializes in the treatment 
of personality disorder. 
• Aged less than 18 or older 
than 65; 
• Currently receiving 
treatment through another 
service; 
• Diagnosed with bipolar 
disorder; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
• Diagnosed with substance 
dependency and/or misuse; 
and 
• Intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent. 
 
Mentalization-based 
therapy: comprising weekly 
individual and group 
psychotherapy sessions. 
Participants were also 
prescribed psychotropic 
medication as required. 
Structured case 
management: comprising 
three monthly individual and 
group therapy sessions based 
on a counselling model 
involving a supporting 
approach combined with 
case management, advocacy 
support, and problem-solving 
therapy. Participants were 
also prescribed psychotropic 
medication as required. 
Repetition of SH: hospital 
records. 
Depression: Beck 
Depression Inventory (BDI). 
Functioning: Global 
Assessment of Functioning 
(GAF). 
Mental health: hospital 
records, including duration 
of hospital admission, 
perceptions for any 
psychotropic medication, 
Global Symptom Index 
(GSI), and Symptom 
Checklist-90 (SCL-90). 
Problem-Solving: Inventory 
of Interpersonal Problems, 
circumflex version. 
Social Adjustment: Social 
Adjustment Scale-self-report. 
Suicide: unclear how this 
outcome was ascertained. 
Nature of the trial suggests 
participants and clinical 
personnel not blind to 
treatment allocation. 
Beautrais  
(2010) 
New Zealand 153 174 33.6 
(NS) 
66.1 Patients admitted to a 
psychiatric emergency 
service following an 
episode of self-harm or 
attempted suicide. 
• Aged less than 16; and 
• Insufficient language 
ability. 
Postcards: series of six 
postcards mailed at 2 and 6 
weeks and again at 3, 6, 9, 
and 12 months post-
discharge. Postcards offered 
outreach, encouraging 
participants to make contact 
with the service in times of 
distress. 
Repetition of SH: medical 
records and hospital records. 
Suicide: unclear how this 
outcome was ascertained. 
Participants not blind to 
allocation. Imbalance 
between intervention and 
control groups for number 
with prior admissions for 
self-harm. Adjusting for this 
reduced effect on repetition 
of self-harm to non-
significance. 
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TAU: comprising crisis 
assessment and referral to 
inpatient and/or community-
based mental health services 
as required. 
Bennewith 
(2002) 
UK 964 968  58.8 Patients presenting to 
hospital following an 
episode of self-harm and 
who are registered with 
one of the participating 
primary care practices. 
• Aged less than 16; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
• Residing outside catchment 
area and/or homelessness; 
and 
• Residing in prison and/or 
custodial environment. 
Letter to general 
practitioner: comprising a 
letter from the patient’s 
treating general practitioner 
inviting the patient to a 
consultation. 
TAU: could comprise 
ongoing general practitioner 
care, referral for psychiatric 
treatment, and/or other 
referrals. 
Repetition of SH: medical 
records. 
Nature of the trial suggests 
participants and clinical 
personnel not blind to 
treatment allocation. 
Additionally, no information 
on outcome assessor blinded 
provided.  
Brown  
(2005) 
USA 60 60 35.0 
(10.3) 
60.8 Patients presenting to 
hospital following a 
suicide attempt. 
• Aged less than 16; 
• Intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent; 
• Insufficient language 
ability; and 
• Presence of a physical 
illness and/or disability that 
would preclude attendance 
at follow-up appointments. 
CBT-based psychotherapy: 
comprising 10 sessions of 
manualized cognitive-
behavioral therapy. 
TAU: no details provided. 
Repetition of SH: self-
report. 
Depression: BDI and 
Hamilton Rating Scale for 
Depression (HRSD). 
Hopelessness: Beck 
Hopelessness Scale (BHS). 
Suicidal Ideation: Beck 
Scale for Suicidal Ideation 
(BSSI). 
Suicide: unclear how this 
outcome was ascertained. 
Participants, clinical 
personnel, and outcome 
assessors not blind to 
treatment allocation. 
Carter  
(2005) 
Australia 378 394 NS 67.9 Patients presenting to a 
hospital-based toxicology 
service following an 
episode of intentional self-
poisoning. 
• Aged less than 16; 
• Engaged in self-injury only; 
• Intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent; 
• Insufficient language 
ability; 
• Residing outside catchment 
area and/or homelessness; 
and 
• Violence risk. 
Postcards: series of eight 
postcards mailed 1, 2, 3, 4, 6, 
8, 10, and 12 months post-
discharge. Postcards offered 
outreach, encouraging 
participants to make contact 
with the service in times of 
distress. 
TAU: no details provided. 
Repetition of SH: hospital 
records. 
Suicide: mortality register. 
Participants and clinical 
personnel not blind to 
allocation. Twenty 
participants randomized to 
control group mistakenly 
received intervention but 
were included in control 
group for all analyses. 
Cedereke  
(2002) 
Sweden 107 109  66.2 Patients treated in general 
hospitals following a 
suicide attempt. 
• Insufficient language 
ability; and 
• No telephone connection. 
 
Telephone contact: 
comprising two telephone 
calls (20-45 minutes) at 4 
and 8 months post-discharge 
encouraging participants to 
receive treatment at times of 
distress. 
TAU: no details provided. 
Repetition of SH: self-
report. 
Functioning: GAF. 
Mental health: SCL-90 and 
GSI. 
Suicidal ideation: BSSI. 
Suicide: mortality register. 
Nature of the trial suggests 
participants and clinical 
personnel not blind to 
treatment allocation. 
Additionally, no information 
on outcome assessor blinded 
provided. 
Clarke  
(2002) 
UK 220 247 33.0 
(NS) 
56.3 Patients presenting to 
hospital following an 
episode of self-harm. 
• Aged less than 16; 
• Currently enrolled in full-
time secondary education; 
and 
Case management: 
comprising psychosocial 
assessment, development of 
a negotiated care plan, and 
referral to a case managed 
Repetition of SH: hospital 
records. 
Suicide: unclear how this 
outcome was ascertained. 
 
Participants and clinical 
personnel not blind to 
allocation. Data on suicides 
had to be requested from 
authors, suggesting selective 
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• Residing outside catchment 
area and/or homelessness. 
 
who helped the patient 
identify and access suitable 
services as required. 
TAU: could involve triage, 
referral for medical and/or 
psychosocial assessment, and 
treatment as required. 
reporting bias make have 
been present. 
Crawford 
(2010) 
UK 51 52  48.5 Consecutive admissions to 
an emergency department 
following an episode of 
self-harm and who were 
diagnosed with alcohol 
misuse according to scores 
on the Paddington Alcohol 
Test. 
• Aged less than 18; 
• Currently receiving AOD 
treatment through another 
service and/or those who 
requested a referral for 
AOD treatment; 
• Intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent; 
• Insufficient language 
ability; and 
• Residing outside catchment 
area and/or homelessness. 
 
Brief alcohol counselling: 
comprising a one-off (30 
minute) appointment with an 
alcohol treatment nurse 
specialist. Session involved 
assessment and discussion of 
both current and previous 
drinking behaviors, provision 
of a health information 
leaflet on the damaging 
effects of excessive alcohol 
consumption, recommended 
limits for alcohol 
consumption, and the contact 
details of a nationally-based 
alcohol misuse help line. 
Participants could also be 
referred to individual 
counselling or detoxification 
services as required. 
TAU: comprising a health 
information leaflet advising 
on the damaging effects of 
excessive alcohol 
consumption, and the contact 
details of a nationally-based 
alcohol misuse help line. 
Repetition of SH: hospital 
records 
Alcohol use: Alcohol Use 
Disorders Identification Test 
(AUDIT). 
Mental health: General 
Health Questionnaire-12 
(GHQ-12). 
Personality disorder: 
Assessment of Personality – 
Abbreviated Scale. 
Suicide: collateral informant 
report. 
Treatment satisfaction: 
Client Satisfaction 
Questionnaire. 
 
 
Participants and clinical 
personnel not blind to 
treatment allocation. Data on 
suicides had to be requested 
from authors, suggesting 
selective reporting bias may 
have been present. 
Davidson 
(2014) 
UK 14 6 NS Not 
reported. 
Patients admitted to the 
medical receiving ward of 
the local accident and 
emergency department 
following an episode of 
self-harm. 
• Aged less than 18 or older 
than 65; and 
• Intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent. 
 
CBT-based psychotherapy: 
manualized CBT comprising 
psychoeducation to help 
participants understand self-
harm, potential alternative 
behaviors, and referral to 
further mental health care 
where necessary. 
TAU: could involve referral 
to community mental health 
teams, appointments with 
psychiatrists, a community 
psychiatric nurse, and/or 
inpatient psychiatric 
treatment as required. 
Repetition of SH: self-
report according to Acts of 
Deliberate Self-Harm 
Inventory. 
Alcohol use: AUDIT. 
Anxiety: Hospital Anxiety 
and Depression Scale 
(HADS). 
Depression: HADS. 
Suicidal ideation: BSSI. 
Suicide: unclear how this 
outcome was ascertained. 
Treatment use: number of 
appointments ascertained 
from self-report. 
 
Nature of trial suggests 
participants and clinical 
personnel not blind to 
treatment allocation. 
Imbalance between the 
intervention and control 
groups in terms of history of 
previous self-harm, anxiety, 
and depression scores. 
Authors did not adjust for 
these differences in their 
analyses. Data on repetition 
of self-harm and depression 
had to be requested from 
authors, suggesting selective 
reporting bias may have been 
present. 
Dubois  
(1999) 
France 51 51 22.3 
(5.8) 
79.4 Patients attending any 
emergency department 
following self-harm 
• Aged less than 15 or older 
than 34; 
CBT-based psychotherapy: 
manualized CBT comprising 
5 sessions delivered during 
Repetition of SH: unclear 
how this outcome was 
ascertained. 
Nature of trial suggests 
participants and clinical 
personnel not blind to 
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• Currently receiving 
treatment through another 
service. 
the first month post-
discharge. 
TAU: could involve 
assessment by a clinical 
psychiatrist and referral for 
follow-up with either a 
psychiatrist or a clinical 
psychologist. 
Functioning: GAF. 
Suicide: unclear how this 
outcome was ascertained. 
allocation. Unclear if 
outcome assessor also not 
blind to allocation. Less than 
two-thirds of participants in 
the intervention group 
attended all three treatment 
sessions. 
Evans  
(1999a) 
UK 417 410  55.4 Patients admitted to 
general hospitals following 
an episode of self-harm. 
• Currently receiving 
treatment through another 
service and/or referred for 
psychiatric treatment; 
• Diagnosed with substance 
dependency and/or misuse;  
• Residing outside catchment 
area and/or homelessness; 
and 
• Violence risk. 
Emergency card: 
comprising an emergency 
card offering a 24-hour 
service for crisis telephone 
consultation with an on-call 
psychiatrist at times of 
distress. 
TAU: no details provided. 
Repetition of SH: hospital 
records. 
Suicide: Coroner’s records 
and mortality statistics. 
Nature of trial suggests 
participants and clinical 
personnel not blind to 
treatment allocation. 
Evans  
(1999b) 
UK 18 16 NS 61.8 Patients admitted to one of 
two general hospitals 
following an episode of 
self-harm. 
• Aged less than 16 or older 
than 50; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms;  
• Diagnosed with substance 
dependency and/or misuse; 
and 
• Intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent. 
 
CBT-based psychotherapy: 
comprising between 2 and 6 
sessions of manualized 
assisted CBT including 
sessions on basic cognitive 
techniques, problem-solving, 
emotion regulation training, 
and relapse prevention in 
those diagnosed with 
personality disorders. 
TAU: could involve contact 
with social workers (25.0%), 
psychiatrists (31.3%), 
community mental health 
teams (18.9%). 12.5% of the 
TAU group did not receive 
any form of treatment, whilst 
the treatment received by the 
remaining 12.3% was not 
recorded. 
Repetition of SH: self-
report using the Linehan 
Parasuicide History 
Interview supplemented by 
hospital records. 
Anxiety: HADS. 
Depression: HADS. 
Functioning: Social 
Functioning Questionnaire. 
Nature of trial suggests 
participants and clinical 
personnel not blind to 
allocation. Five participants 
in the intervention group did 
not see a 
therapist and instead 
received 
bibliotherapy whilst one 
further participant received 
no intervention. Authors 
undertook per protocol 
analyses only, as data from 2 
participants who dropped out 
following randomization and 
treatment allocation was not 
analyzed. 
Fleischmann 
(2008) 
Multinational 922 945  58.2 Patients presenting to 
emergency care settings 
following an episode of 
self-harm or self-
poisoning. 
• Diagnosed with any 
physical illness and/or 
disability and/or any mental 
illness that would preclude 
assessment and/or 
attendance at follow-up 
appointments; 
• Insufficient language 
ability; 
• Refusal to provide informed 
consent; and 
• Residing outside catchment 
area and/or homelessness. 
Brief information and 
support: comprising one-off 
information session on 
suicidal behavior as a signal 
of distress, risk and 
protective factors for suicide, 
basic epidemiology, 
information on repetition 
risk, alternatives to suicidal 
behaviors, and referral 
options. Participants could 
also elect to receive 
telephone or home visits to 
provide referral support. 
Repetition of SH: self-
report using an instrument 
based largely on the 
European Parasuicide Study 
Interview Schedule. 
All cause mortality: 
collateral informant report. 
Suicide: collateral informant 
report. 
Nature of trial suggests 
clinical personnel not blind 
to treatment allocation. No 
information on outcome 
assessor blinding provided. 
No data on reasons for 
participant attrition provided, 
nor were analyses conducted 
according to intention-to-
treat principles. Some 
evidence of selective 
outcome reporting bias as 
information on treatment 
adherence, depression, 
hopelessness, impulsivity, 
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TAU: typically involved 
acute treatment for medical 
complications following self-
harm/self-poisoning without 
further treatment or support. 
suicidal intent, have been 
published for some (i.e., 
China, India, and the Islamic 
Republic of Iran) but not all 
(i.e., Australia, Vietnam) 
study sites.  
Gibbons  
(1978) 
UK 200 200 NS 71.0 Patients presenting to 
accident and emergency 
departments following an 
episode of deliberate self-
poisoning. 
• Aged less than 17; 
• Currently receiving 
treatment through another 
service and/or referred for 
psychiatric treatment; 
• Engaged in self-injury only; 
• Refusal to provide informed 
consent; and 
• Residing in prison and/or 
custodial environment. 
 
CBT-based psychotherapy: 
crisis-oriented problem-
solving based treatment 
provided in the home with 
additional emotional 
regulation treatment 
elements. 
TAU: could include referral 
to general practitioners 
(54.0%), psychiatric 
treatment services (33.0%), 
or another, unspecified 
treatment service (13.0%). 
Repetition of SH: hospital 
and/or medical records. 
Depression: BDI. 
Problem-solving: self-
reported problems. 
Treatment use: hospital 
and/or medical and/or social 
welfare records. 
Nature of trial suggests 
participants and clinical 
personnel not blind to 
allocation. 
Gratz  
(2006) 
USA 13 11  100.0 Clinician referrals or self-
referrals to a specialist 
personality disorder 
treatment service for 
women. 
• Aged less than 18 or older 
than 60; 
• Attended a DBT skills 
program within the past 6 
months; 
• Diagnosed with bipolar 
disorder; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms;  
• Diagnosed with substance 
dependency and/or misuse;  
• Males; and 
• Suicide risk. 
 
Emotion-regulation group 
psychotherapy: involved 
weekly emotion-regulation 
group-based therapy and 
individual emotion 
regulation therapy sessions 
designed to develop 
awareness and understanding 
of self-harming behavior, 
skills to engage in goal-
directed behaviors whilst 
inhibiting impulsive 
behaviors without 
experiencing negative 
emotions, and developing 
confidence in using 
situationally appropriate 
strategies to moderate either 
the intensity or duration of 
negative emotions, and 
gaining a sense of acceptance 
of negative emotional states. 
TAU: could include referral 
to individual emotion 
regulation therapy sessions 
and/or group-based 
psychotherapy (not emotion-
focused). 
Repetition of SH: self-
report using the Deliberate 
Self-Harm Inventory 
(DSHI). 
Anxiety: Depression 
Anxiety Stress Scale 
(DASS). 
Depression: DASS. 
Emotion regulation: 
Difficulties in Emotion 
Regulation Scale (DERS). 
Experiential Avoidance: 
Acceptance and Action 
Questionnaire (AAQ). 
Personality disorder: 
Borderline Evaluation of 
Severity over Time (BEST). 
Stress: DASS. 
Suicide: unclear how this 
outcome was ascertained. 
 
No information on allocation 
concealment was provided. 
Nature of trial suggests 
participants and clinical 
personnel not blind to 
allocation. Additionally, 
outcome assessors not blind 
to treatment allocation. 
Authors undertook per 
protocol analyses only, as 
data from 2 participants who 
dropped out following 
randomization and treatment 
allocation was not analyzed. 
Gratz  
(2014) 
USA 31 31  100.0 Clinician referrals or self-
referrals to a specialist 
personality disorder 
treatment service for 
women. 
• Aged less than 18 or older 
than 60; 
• Diagnosed with bipolar 
disorder; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms;  
Emotion-regulation group 
psychotherapy: involved 
weekly emotion-regulation 
group-based therapy and 
individual emotion 
regulation therapy sessions 
designed to develop 
Repetition of SH: self-
report using the DSHI and 
the Self-Harm Inventory. 
Anxiety: DASS. 
Depression: BDI and DASS. 
Emotion regulation: DERS. 
No information on allocation 
concealment was provided. 
Nature of trial suggests 
participants and clinical 
personnel not blind to 
allocation. 
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• Diagnosed with substance 
dependency and/or misuse; 
and 
• Males. 
awareness and understanding 
of self-harming behavior, 
skills to engage in goal-
directed behaviors whilst 
inhibiting impulsive 
behaviors without 
experiencing negative 
emotions, and developing 
confidence in using 
situationally appropriate 
strategies to moderate either 
the intensity or duration of 
negative emotions, and 
gaining a sense of acceptance 
of negative emotional states. 
TAU: could include referral 
to individual emotion 
regulation therapy sessions 
and/or group-based 
psychotherapy (not emotion-
focused). 
Experiential Avoidance: 
AAQ. 
Quality of life: Quality of 
Life Inventory (QLI). 
Personality disorder: 
Zanarini Rating Scale for 
Borderline Personality 
Disorder and the BEST. 
Problem-solving: Inventory 
of Interpersonal Problems 
scores. 
Social Functioning: 
Sheehan Disability Scale. 
Stress: DASS. 
Suicide: unclear how this 
outcome was ascertained. 
Guthrie  
(2001) 
UK 58 61 31.2 
(1.5) 
55.5 Patients presenting to 
hospital following an 
episode of deliberate self-
poisoning. 
• Aged less than 18 or older 
than 65; 
• Currently receiving 
treatment through another 
service and/or referred for 
psychiatric treatment; 
• Insufficient language 
ability; 
• Not registered with a GP; 
and 
• Residing outside catchment 
area and/or homelessness. 
 
CBT-based psychotherapy: 
weekly (50 minute) sessions 
of individual, home-based 
psychodynamic interpersonal 
therapy. 
TAU: typically this involved 
assessment by the treating 
doctor in the emergency 
department, referral to 
outpatient psychiatric 
treatment, addiction services, 
or general practitioner 
management. 
Repetition of SH: self-
report supplemented by 
medical records. 
Depression: BDI. 
Suicidal ideation: BSSI. 
Suicide: unclear how this 
outcome was ascertained. 
Treatment satisfaction: 10-
point idiosyncratic scale. 
Treatment use: medical 
records. 
 
Nature of trial suggests 
participants and clinical 
personnel not blind to 
allocation. Although 
outcome assessors blind to 
allocation, data on repetition 
of SH obtained from self-
report. 
Harned  
(2014) 
USA 19 7  100.0 Patients seeking treatment 
from a specialist service 
for suicidal women with 
comorbid borderline 
personality disorder and 
post-traumatic stress 
disorder. 
• Aged less than 18 or older 
than 60; 
• Diagnosed with bipolar 
disorder; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms;  
• Intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent;  
• Legally mandated to a 
specific form of psychiatric 
treatment; and 
• Males. 
DBT (prolonged exposure): 
weekly individual 
psychotherapy sessions, 
group skills training, and 
telephone counselling as 
required. The prolonged 
exposure protocol enabled 
participants to receive longer 
individual therapy sessions 
per week. 
DBT (regular exposure): 
DBT delivered according to 
the original exposure 
protocol. Involved weekly 
individual psychotherapy 
sessions, group skills 
training, and telephone 
counselling as required.  
Repetition of SH: self-
report using the Suicide 
Attempt Self-Injury 
Interview (SASII). 
Anxiety: HADRS. 
Depression: HADRS. 
Dissociation experiences: 
Dissociative Experiences 
Scale-Taxon. 
Mental health: GSI and 
Brief Symptom Inventory 
(BSI). 
Post-traumatic stress 
disorder: PTSD Symptom 
Scale-Interview.  
Shame: Experiences of 
Shame Scale.  
Suicide: unclear how this 
outcome was ascertained. 
Participants and clinical 
personnel not blind to 
treatment allocation.  
35	
	
Trauma cognitions: 
Trauma-Related Guilt 
Inventory. 
Treatment satisfaction: 
Client Satisfaction 
Questionnaire-8. 
Hassanian-
Moghaddam 
(2011) 
Islamic 
Republic of 
Iran 
1150 1150 24.1 
(8.1) 
66.4 Admissions to a specialist 
poisons hospital. 
• Aged less than 12; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms;  
• Intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent;  
• Insufficient language 
ability; 
• Residing outside catchment 
area and/or homelessness; 
and 
• Violence risk. 
Postcards: series of eight 
postcards sent 1, 2, 4, 5, 6, 8, 
10, and 12 months post-
discharge encouraging 
participants to make contact 
with the investigators during 
times of distress. 
TAU: correspondence with 
study authors revealed that 
follow-up care in the Islamic 
Republic of Iran is typically 
poor. Contact is mainly 
hospital- or office-based; 
community-based mental 
health services are virtually 
non-existent. Additionally, 
psychiatric inpatient beds are 
often at 100% occupancy, 
necessitating the use of short 
admissions and frequent 
readmissions. 
Repetition of SH: self-
report supplemented by 
hospital records. 
Suicidal Ideation: self-
report.  
Suicide: collateral informant 
report supplemented by 
official death records. 
Treatment use: self-report. 
 
Nature of trial suggests 
participants not blind to 
allocation. Outcome 
assessors not blind to 
allocation. Data on suicides 
had to be obtained from 
study authors, suggesting the 
presence of selective 
outcome reporting bias. 
Hatcher  
(2011) 
New Zealand 253 299 33.7 
(12.9) 
68.8 Patients admitted to 
hospital following an 
episode of self-harm. 
• Aged less than 16; 
• Attended a DBT skills 
program and/or other 
specific treatment for 
borderline personality 
disorder; 
• Currently enrolled in full-
time secondary education; 
and 
• Intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent. 
CBT-based psychotherapy: 
involved problem-solving 
therapy with sessions 
focused on problem 
orientation, problem listing, 
definition, brainstorming 
alternative coping strategies, 
and development of a crisis 
plan. 
TAU: involved a one-off 
psychosocial assessment 
conducted by a mental health 
professional.  
Repetition of SH: hospital 
records 
Anxiety: HADRS. 
Depression: HADRS. 
Hopelessness: BHS. 
Problem-solving: Social 
Problem Solving Inventory-
Revised.  
Suicidal Ideation: BSSI. 
Suicide: Coroner’s records. 
 
Use of Zelen’s post-consent 
design suggests participants 
not blind to allocation. 
Nature of the trial suggests 
clinical personnel not blind 
to treatment allocation. Data 
on suicides had to be 
obtained from study authors, 
suggesting the presence of 
selective outcome reporting 
bias. 
Hatcher  
(2015) 
New Zealand 327 357  67.8 Patients admitted to 
hospital following an 
episode of self-harm. 
• Aged less than 17; 
• Currently enrolled in full-
time secondary education;  
• Intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent; and 
• Self-identify as having 
Māori ancestry (these 
patients were eligible for 
inclusion in Hatcher, 2016). 
	
Multimodal intervention:	
between 4 and 6 sessions of 
problem-solving therapy, 
series of eight postcards sent 
1, 2, 3, 4, 6, 8, 10, and 12 
months post-discharge, 
between 1 and 2 face-to-face 
or telephone support 
sessions, improved access to 
primary care through the 
provision of a voucher that 
could be used to access one 
free consultation with a 
Repetition of SH: self-
report supplemented by 
hospital and medical records. 
Anxiety: HADRS. 
Cultural identity: Sense of 
Belonging Instrument-P and 
Multi-Ethnic Identity. 
Depression: HADS. 
Hopelessness: BHS. 
Quality of life: EuroQual-
5D.  
Use of Zelen’s post-consent 
design suggests participants 
not blind to allocation. 
Nature of the trial suggests 
clinical personnel not blind 
to treatment allocation. Data 
on suicides had to be 
obtained from study authors, 
suggesting the presence of 
selective outcome reporting 
bias.  
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general practitioner, 
development of a risk 
management strategy, and a 
cultural assessment. 
TAU: could involve referral 
to multidisciplinary 
treatment teams for 
psychiatric risk/needs 
assessment, psychiatric 
intervention, or both, referral 
to a crisis team, or referral to 
community-based alcohol 
and drug treatment teams as 
required.  
Treatment use: self-report 
supplemented by medical 
records. 
Social Functioning: Social 
Functioning Questionnaire-
36. 
Suicidal Ideation: BSSI. 
Suicide: Coroner’s records. 
 
Hatcher  
(2016) 
New Zealand 95 72  65.3 Patients admitted to 
hospital following an 
episode of self-harm and 
who self-identify as having 
Māori ancestry. 
• Aged less than 17; 
• Currently enrolled in full-
time secondary education; 
and 
• Intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent. 
Culturally-adapted 
multimodal intervention:	
between 4 and 6 sessions of 
problem-solving therapy, 
series of eight postcards sent 
1, 2, 3, 4, 6, 8, 10, and 12 
months post-discharge, 
between 1 and 2 face-to-face 
or telephone support 
sessions, improved access to 
primary care through the 
provision of a voucher that 
could be used to access one 
free consultation with a 
general practitioner, 
development of a risk 
management strategy, and a 
cultural assessment. This 
intervention was designed to 
be culturally appropriate for 
persons of Māori ethnicity. 
TAU: could involve referral 
to multidisciplinary 
treatment teams for 
psychiatric risk/needs 
assessment, psychiatric 
intervention, or both, referral 
to a crisis team, or referral to 
community-based alcohol 
and drug treatment teams as 
required. 
Repetition of SH: self-
report supplemented by 
hospital and medical records. 
Anxiety: HADS. 
Cultural identity: Sense of 
Belonging Instrument-P, 
Multi-Ethnic Identity, and 
Cultural Impact Profile. 
Depression: HADRS. 
Hopelessness: BHS. 
Quality of life: EuroQual-
5D.  
Treatment use: self-report 
supplemented by medical 
records.  
Social Functioning: Social 
Functioning Questionnaire-
36 scores. 
Suicide: Coroner’s records. 
 
Use of Zelen’s post-consent 
design suggests participants 
not blind to allocation. 
Nature of the trial suggests 
clinical personnel not blind 
to treatment allocation. Data 
on suicides had to be 
obtained from study authors, 
suggesting the presence of 
selective outcome reporting 
bias. 
Hawton  
(1981) 
UK 48 48  69.8 Patients admitted to 
general hospitals following 
an episode of deliberate 
self-poisoning. 
• Aged less than 16; 
• Currently receiving 
treatment through another 
service and/or referred for 
psychiatric treatment; 
• Currently receiving AOD 
treatment and/or referred for 
AOD treatment; 
Home-based 
psychotherapy: series of 
home-based, therapy 
sessions with a flexible 
schedule delivered according 
to the treating therapists’ 
assessment of risk/needs. 
Open telephone access to the 
Repetition of SH: self-
report.  
Anxiety: Lorr and McNair 
Mood Scale sub-scale. 
Depression: Lorr and 
McNair Mood Scale sub-
scale. 
Nature of the trial suggests 
participants and clinical 
personnel not blind to 
treatment allocation. 
Participant attrition was 6/96 
(6.2%) at post-treatment and 
15/96 (15.6%) at the 6-
month follow-up 
assessments. No information 
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• Engaged in self-injury only; 
• Refusal to provide informed 
consent; 
• Residing outside catchment 
area and/or homelessness; 
and 
• Suicide risk. 
local general hospital was 
also available. 
TAU: weekly outpatient 
therapy sessions delivered at 
the local general hospital. 
Social Adjustment: 
modified version of the 
Social Adjustment Scale. 
Suicidal Ideation: 
idiosyncratic 7-item Suicide 
Ideation Scale. 
Suicidal Intent: Beck 
Suicide Intent Scale (BSIS). 
Suicide Risk: Buglass Risk 
of Repetition Scale. 
Treatment use: medical 
records. 
on whether analyses were 
conducted according to 
intention-to-treat principles 
provided. 
Hawton  
(1987) 
UK 41 39 29.3 
(NS) 
66.3 Patients admitted to a 
general hospital following 
an episode of self-
poisoning. 
• Aged less than 16; 
• Engaged in self-injury only; 
• Not in need of ongoing 
psychiatric treatment; 
• Not registered with a GP; 
and 
• Residing outside catchment 
area and/or homelessness. 
CBT-based psychotherapy: 
up to 8 sessions (up to 45 
minutes) of problem-solving 
therapy. 
TAU: general practitioner-
led care which could include 
individual support, marriage 
counselling, and referral for 
psychiatric treatment, as 
required. 
Repetition of SH: self-
report supplemented by 
hospital and medical records. 
Depression: BDI. 
Mental health: General 
Health Questionnaire-28. 
Problem-solving: self-
report. 
Social Adjustment: 
modified version of the 
Social Adjustment Scale. 
Suicide Intent: BSIS. 
Suicide Risk: Buglass Risk 
of Repetition Scale. 
Suicide: collateral informant 
report. 
Treatment satisfaction: 
scores on an idiosyncratic 
scale of attitudes towards 
treatment. 
Nature of trial suggests 
participants and clinical 
personnel not blind to 
allocation. 
Husain  
(2014) 
Pakistan 108 113 23.1 
(5.5) 
68.8 Patients admitted to the 
medical unit of a 
university hospital 
following an episode of 
self-harm. 
• Aged less than 16 or older 
than 64; 
• Currently receiving 
treatment through another 
service and/or referred for 
psychiatric treatment; 
• Diagnosed with bipolar 
disorder; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
• Diagnosed with substance 
dependency and/or misuse; 
and 
• Intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent; and 
• Residing outside catchment 
area and/or homelessness. 
CBT-based psychotherapy: 
manualized, culturally-
adapted, problem-solving 
therapy involving sessions 
on evaluating the self-harm 
attempt, development of 
crisis management skills, 
training in the use of 
problem-solving and 
cognitive-behavioral 
techniques, emotion 
regulation skills, 
interpersonal skills, and 
relapse prevention. 
TAU: not clearly specified, 
however, control patients are 
not routinely referred to 
psychiatric or psychological 
services. 
Repetition of SH: self-
report using the (SASII). 
Depression: BDI  
Hopelessness: BHS. 
Quality of life: EuroQual-
5D.  
Problem-solving: Coping 
Resource Inventory. 
Suicidal Ideation: BSSI 
scores.  
Suicide: unclear how this 
outcome was ascertained. 
Treatment use: Client 
Service Receipt Inventory. 
 
Participants and clinical 
personnel not blind to 
allocation. 
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Hvid  
(2011) 
Denmark 69 64 37.1 
(17.9) 
84.1 Patients admitted to an 
emergency or clinical 
department following an 
episode of self-harm. 
• Aged less than 12; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
• Intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent; and 
• Insufficient language 
ability. 
 
Case management: 
delivered according to the 
Baerum model. Sessions 
involved solution-focused 
problem-solving therapy, 
adherence therapy, therapist 
continuity. Assertive 
outreach via home visits, 
telephone calls, email 
measures, text messages, was 
also used to improve 
treatment adherence. 
TAU: general practitioner-
led management with referral 
to further psychiatric or 
psychological treatment as 
required. 
Repetition of SH: hospital 
records. 
Suicide: Coroner’s records. 
Participants and clinical 
personnel not blind to 
allocation. 
Kapur  
(2013) 
UK 33 33 NS Not 
reported. 
Admissions to emergency 
departments following an 
episode of self-harm. 
• Currently receiving 
treatment through another 
service and/or referred for 
psychiatric treatment; 
• No telephone connection; 
and 
• Residing outside catchment 
area and/or homelessness. 
 
Postcards: series of letters 
mailed at 1, 2, 3, 6, 8, and 12 
months post-discharge, 
mailing of an information 
leaflet listing both local and 
national sources of support, 
and two semi-structured 
telephone calls all designed 
to facilitate referral to 
appropriate sources of 
specialist treatment as 
required. 
TAU: could involve referral 
to mental health services, 
social services, or voluntary 
sector services as 
appropriate. 
Repetition of SH: hospital 
records 
Suicide: unclear how this 
outcome was ascertained. 
 
 
No information on allocation 
concealment provided. 
Nature of trial suggests 
participants and clinical 
personnel not blind to 
treatment allocation. 
Kawanishi 
(2014) 
Japan 460 454 42.3 
(14.9) 
56.2 
 
Admissions to emergency 
departments following a 
suicide attempt. 
• Aged less than 20; 
• Diagnosed with any 
personality disorder without 
any comorbid axis one 
mental disorder; 
• Intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent;  
• Insufficient language 
ability; 
• Residing outside catchment 
area and/or homelessness; 
and 
• Unable to commit to 
schedule of regular face-to-
face in-hospital 
appointments. 
 
Case management: 
involving contact with 
patients at week 1 and 
months 1, 2, 3, 6, 12, and 18 
post-discharge. Sessions 
were designed to collect 
information on treatment 
status, identify any problems 
that could interfere with 
adherence, and to coordinate 
referral to psychiatric 
treatment, general 
practitioners, social services, 
and other treatment services 
as needed, Participants also 
received access to a dedicate 
website designed to provide 
further information and 
resources. 
Repetition of SH: unclear 
how this outcome was 
ascertained 
All cause mortality: 
mortality register. 
Hopelessness: BHS. 
Quality of life: SFQ-36. 
Suicide: mortality register. 
Treatment use: medical 
records. 
Participants and clinical 
personnel not blind to 
allocation. Data on some pre-
specified outcomes (i.e., 
number of repeat self-harm 
episodes, hopelessness 
scores) are yet to be 
published. Selective outcome 
reporting bias therefore 
cannot be ruled out at 
present. Additionally, the 
sample was biased towards 
more compliant patients. 
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EUC: no details on content 
provided. 
Lieberman 
(1981) 
USA 12 12  66.7 Referrals from psychiatric 
emergency services and/or 
accident and emergency 
departments following an 
episode of self-harm. 
• Aged less than 18 or older 
than 47; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
• Diagnosed with substance 
dependency and/or misuse; 
and 
• Intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent. 
Brief behavioral therapy: 
sessions covered social skills 
training, anxiety 
management, and family 
therapy. Patients were treated 
in a therapeutic milieu with a 
token economy. Aftercare 
was arranged through a 
community mental health 
center and/or a private 
therapist as required. 
Insight-oriented therapy: 
sessions involved individual 
therapy, group therapy, 
psychodrama, and family 
therapy. Patients were treated 
in a therapeutic milieu with a 
token economy. Aftercare 
was arranged through a 
community mental health 
center and/or a private 
therapist as required. 
Repetition of SH: self-
report. 
Assertiveness: Assertiveness 
Questionnaire. 
Depression: Zung 
Depression Rating Scale, 
BDI, and the Minnesota 
MultiPhasic Inventory, 
depression subscale (MMPI-
D). 
Reinforcing Behaviors: 
Reinforcement Survey 
Schedule. 
Fear: Fear Survey Schedule. 
 
No information on allocation 
concealment provided. 
Nature of trial suggests 
clinical personnel not blind 
to treatment allocation. No 
information on outcome 
assessor blinding provided. 
Four participants who 
dropped out of treatment 
were not included in 
subsequent analyses 
suggesting per protocol 
analyses were undertaken. 
Linehan  
(1991) 
USA 32 31 NA 100.0 Referrals to a personality 
disorder service 
• Aged less than 18 or older 
than 45; 
• Diagnosed with bipolar 
disorder; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
• Diagnosed with substance 
dependency and/or misuse; 
and 
• Diagnosed with an 
intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent. 
DBT: weekly sessions of 
individual therapy (1 hour), 
group skills training (2.5 
hours), telephone 
consultation as required, and 
weekly therapist team 
meetings. 
TAU: referral to alternative 
forms of therapy (no 
additional information 
provided).  
Repetition of SH: self-
report using the Linehan 
Parasuicide History 
Interview. 
Depression: BDI. 
Hopelessness: BHS and the 
Reasons for Living Inventory 
Suicidal Ideation: Schotte 
Scale for Suicidal Ideators. 
Suicide: unclear how this 
outcome was ascertained. 
Treatment use: self-report 
using the Treatment History 
Interview. 
 
Nature of trial suggests 
participants and clinical 
personnel not blind to 
allocation. Data from 24/63 
(38.1%) 
participants omitted from 24 
month follow-up assessment 
suggesting analyses were 
based on per protocol 
principles.  
Linehan  
(2006) 
USA 52 49  100.0 Clinical referrals to 
inpatient units, emergency 
rooms, and outpatient 
clinics.  
• Aged less than 18 or older 
than 45; 
• Diagnosed with bipolar 
disorder; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
• Diagnosed with an 
intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent; 
DBT: weekly sessions of 
individual therapy (1 hour), 
group skills training (2.5 
hours), telephone 
consultation as required, and 
weekly therapist team 
meetings. 
Treatment by expert: 
therapists were free to decide 
on the type, duration, 
intensity, and dose of therapy 
they believed was most 
suited to the patient 
Repetition of SH: self-
report using the SASII. 
Depression: HRS-D, 17 item 
Hopelessness: Reasons for 
Living Inventory (reverse 
scored). 
Suicidal ideation: Suicidal 
Behaviors Questionnaire 
(SBQ). 
Suicide: unclear how this 
outcome was ascertained. 
Treatment use: self-report 
using the Treatment History 
Interview. 
No information on allocation 
concealment provided. 
Nature of trial suggests 
participants and clinical 
personnel not blind to 
allocation. 
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• Legally mandated to a 
specific form of psychiatric 
treatment; and 
• Males. 
(minimum of 1 individual 
therapy session per week).  
 
 
Marasinghe 
(2012) 
Sri Lanka 34 34  50.0 Admissions to a general 
hospital following an 
episode of self-harm. 
• Aged less than 15 or older 
than 74; 
• Currently receiving 
treatment through another 
service and/or referred for 
psychiatric treatment; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; and 
• Diagnosed with an 
intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent. 
 
Brief mobile-telephone-
based psychotherapy: up to 
10 sessions of problem-
solving therapy, social 
support, alcohol/drug 
counselling, and meditation 
delivered over mobile 
telephone. Participants also 
received a series of up to 26 
text messages designed to 
encourage participants to 
practice of these techniques. 
Waitlist: participants waited 
6 months and then received 
the intervention. 
Repetition of SH: unclear 
how this outcome was 
ascertained. 
Alcohol use: AUDIT. 
Alcohol/drug dependency: 
Severity of Dependence 
Scale, and the Drug Check 
Problem List. 
Drug use: Drug Check 
Problem List. 
Depression: BDI. 
Social support: Medical 
Outcomes Study. 
Suicidal ideation: BSSI. 
Suicide: unclear how this 
outcome was ascertained. 
Nature of trial suggests 
participants and clinical 
personnel not blind to 
allocation. Data on repetition 
of self-harm, suicide 
reattempts, and suicides had 
to be obtained from study 
authors, suggesting the 
presence of significant 
selective outcome reporting 
bias. 
McAuliffe 
(2014) 
Republic of 
Ireland 
222 211 33.5 
(11.8) 
63.0 Admissions to emergency 
department or an acute 
psychiatric unit. 
• Aged less than 18 or older 
than 64; 
• Diagnosed with any 
physical illness and/or 
disability that would 
preclude assessment and/or 
attendance at appointments; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
• Diagnosed with an 
intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent; 
• Diagnosed with substance 
dependency and/or misuse; 
• Residing outside catchment 
area and/or homeless; and 
• Residing in prison and/or 
custodial environment. 
Group CBT-based 
psychotherapy: manualized 
sessions of problem-solving 
skills training and 
interpersonal problem-
solving skills training 
delivered in a group format. 
TAU: could involve 
assessment by mental health 
staff, referral to acute 
inpatient and/or community-
based mental health services, 
psychotherapy, and 
pharmacotherapy as required.  
Repetition of SH: self-
report (at 6-weeks and 6-
months follow-up) and 
hospital records (at 12 
months). 
Anxiety: Beck Anxiety 
Inventory (BAI). 
Depression: BDI. 
Hopelessness: BHS. 
Impulsiveness: Barratt 
Impulsivity Scale (BIS). 
Problem-solving: Self-
Rated Problem-Solving Scale 
(SRPSS), Means-Ends 
Problem-Solving Procedure 
(MEPS), Optional Thinking 
Test (OTT), and the Current 
Problems List. 
Self-efficacy: Generalized 
Self-Efficacy Scale. 
Social Functioning: Social 
Life Scale. 
Suicidal Ideation: BSSI. 
Suicide: hospital records. 
Participants and clinical 
personnel not blind to 
allocation. Analyses were 
based on per protocol 
principles.  
McLeavey 
(1994) 
Republic of 
Ireland 
19 20  74.3 Admissions to the accident 
and emergency department 
following an episode of 
self-poisoning. 
• Aged less than 15 or older 
than 45; 
• Currently receiving 
treatment through another 
service and/or referred for 
psychiatric treatment; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
Interpersonal problem-
solving skills training: 
manualized sessions 
involving instruction, active 
discussion, reflective 
listening, modelling, 
formulating alternative 
coping strategies, role 
playing, sentence 
Repetition of SH: collateral 
informant report. 
Hopelessness: BHS. 
Problem-solving: MEPS, 
OTT, SRPSS, Awareness of 
Consequences Test, and 
Problems Questionnaire. 
Self-concept: Self-Percep-
tion Scale. 
Random sequence generation 
may have led to selection 
bias as an open numbers 
table was used. Treatment 
allocation also could not be 
concealed as a consequence. 
Nature of trial suggests 
participants and clinical 
personnel not blind to 
allocation. Data from 11/50 
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• Diagnosed with an 
intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent; and 
• Engaged in self-injury only. 
 
completion, and prompting 
exercises. 
Brief problem-solving 
therapy: sessions focus on 
patients’ current problems, 
and aim to prove patients 
gain insight into the causes 
and consequences of these 
problems. Patients do not 
receive any form of specific 
skills training. 
Suicide: unclear how this 
outcome was ascertained. 
 
(22.0%) participants who 
either dropped out of 
treatment and/or were lost to 
follow-up not analyzed. 
Analyses therefore based on 
per protocol principles. 
McMain  
(2009) 
Canada 90 90 30.4 
(9.9) 
86.1 Referrals to specialist 
Centre for Additional and 
Mental Health, as well as 
presentations to general 
hospitals following an 
episode of self-harm. 
• Aged less than 18 or older 
than 60; 
• Diagnosed with any 
physical illness and/or 
disability that would 
preclude use of 
psychoactive medications 
and/or is highly likely to 
necessitate hospital 
treatment; 
• Diagnosed with bipolar 
disorder; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
• Diagnosed with an 
intellectual disability and/or 
organic disorder and/or 
unable to provide informed 
consent;  
• Diagnosed with substance 
dependency and/or misuse;  
• Did not meet criteria for a 
diagnosis of borderline 
personality disorder; and 
• Residing outside catchment 
area and/or homeless. 
DBT: manualized sessions 
of weekly individual therapy 
(1 hour), group skills training 
(2 hours), and telephone-
based coaching (2 hours). 
TAU: general psychiatric 
management involving 
sessions of weekly individual 
therapy focused on 
improving medication 
management. 
Psychoeducation was also 
provided.  
Repetition of SH: self-
report using the SASII. 
Anger: State-Trait Anger 
Inventory (STAI). 
Depression: BDI. 
Mental health: SCL-90. 
Personality disorder: 
Zanarini Rating Scale for 
Borderline Personality 
Disorder (ZRS-BPD). 
Problem-solving: Inventory 
of Interpersonal Problems-
64. 
Quality of life: EQ-5D. 
Suicide: unclear how this 
outcome was ascertained. 
Treatment adherence: 
Reasons for Early 
Termination from Treatment 
Questionnaire. 
Treatment use: self-report 
using the Treatment History 
Interview. 
 
 
Participants and clinical 
personnel not blind to 
allocation. 
Morgan  
(1993) 
UK 101 111  25.0 Admissions to general 
hospitals following a first 
recorded episode of self-
harm. 
• No history of self-harm 
prior to the index episode 
(unclear how this was 
ascertained); and 
• Residing outside catchment 
area and/or homeless. 
Emergency card: provision 
of a card that outlined a 
doctor was always available 
by telephone and could be 
contacted during times of 
distress. 
TAU: referral to general 
practitioners, primary 
healthcare teams, psychiatric 
outpatient treatment, or 
impatient admission as 
required. 
Repetition of SH: medical 
records. 
Treatment use: medical 
records. 
Nature of trial suggests 
participants and clinical 
personnel not blind to 
allocation. No information 
on outcome assessor blinding 
provided. 
Morthorst 
(2012) 
Denmark 123 120 30.8 
(13.2) 
75.7 Admissions to acute 
emergency units, intensive 
care, pediatric units or 
• Aged less than 12; 
• Currently receiving 
treatment through another 
Case management: case 
manager-facilitated sessions 
of crisis intervention, 
Repetition of SH: self-
report, hospital and medical 
records. 
Participants and clinical 
personnel not blind to 
allocation. 
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psychiatric emergency 
rooms. 
service and/or referred for 
psychiatric treatment; 
• Currently receiving 
outreach through social 
services; 
• Diagnosed with bipolar 
disorder; 
• Diagnosed with major 
depression; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
• Diagnosed with an 
intellectual disability and/or 
organic disorder;  
• Residing in prison and/or 
custodial environment; and 
• Residing in other 
institutional environments. 
problem-solving therapy, and 
assertive outreach based on 
motivational support. 
Participants were also 
assisted to attend these 
sessions to improve 
adherence. 
TAU: referral to a range of 
different treatments 
depending on diagnostic, 
clinical, and social needs. 
Treatment could include 
psychiatric assessment, 
substance abuse treatment, 
psychological therapy, 
general practitioner referral, 
and pharmacological 
treatment as required. 
All cause mortality: 
mortality register. 
Suicide: mortality register. 
Treatment use: medical 
records. 
 
Patsiokas  
(1985) 
USA 10 5 NS Not 
reported. 
Admissions to a 
psychiatric ward. 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; and 
• Diagnosed with substance 
dependency and/or misuse. 
 
CBT-based psychotherapy: 
up to 10, 1 hour sessions of 
cognitive restructuring. 
TAU: non-directive therapy 
involving open discussions 
about suicidal behavior, 
problems, and daily life. 
Repetition of SH: N/A. 
Cognitive Flexibility: 
Alternate Uses Scale. 
Hopelessness: BHS. 
Problem-solving: MEPS. 
Suicidal ideation: Self-
Monitoring of Suicidal 
Ideation and BSSI. 
No information on allocation 
concealment provided. 
Nature of trial suggests 
participants and outcome 
assessors not blind to 
allocation. As same therapist 
delivered intervention and 
control therapies, clinical 
personnel also not blind to 
allocation. 
Priebe  
(2012) 
UK 40 40 32.2 
(10.8) 
87.5 Referrals to a specialist 
DBT treatment service. 
• Aged less than 16; 
• Diagnosed with an 
intellectual disability and/or 
organic disorder;  
• Did not meet criteria for any 
personality disorder; 
• Insufficient language 
ability; and 
• Residing outside catchment 
area and/or homeless. 
 
DBT: sessions of individual 
and group-based cognitive 
behavioral therapy, 
mindfulness, validation, 
supportive therapy, and skills 
training. Out of hours 
telephone skills training was 
also available as required. 
TAU: referral back to the 
referee agency where the 
participant was encouraged 
to engage with any therapy 
aside from DBT. Treatment 
therefore could include 
referral to psychiatrists, 
mental health teams, 
counsellors, general 
practitioners, or other user-
run services as required.  
Repetition of SH: self-
report. 
Mental health: BPRS and 
the BSI. 
Personality disorder: ZRS-
BPD. 
Quality of life: Manchester 
Short Assessment of Quality 
of Life. 
Suicide: unclear how this 
outcome was ascertained. 
Treatment use: Client 
Service Receipt Inventory. 
 
No information on allocation 
concealment provided. 
Participants and clinical 
personnel not blind to 
allocation. Data on repetition 
of self-harm and suicides had 
to be obtained from study 
authors, suggesting the 
presence of significant 
selective outcome reporting 
bias. 
Salkovskis 
(1990) 
UK 12 8 27.2 
(6.7) 
50.0 Referrals from the duty 
psychiatrist following an 
episode of self-poisoning 
involving antidepressants 
that necessitated admission 
• Aged less than 16 or older 
than 65; 
• Currently receiving 
treatment through another 
CBT-based psychotherapy: 
up to 5, 1 hour sessions of 
home-based cognitive-
behavioral and problem-
solving therapy. 
Repetition of SH: hospital 
records. 
Depression: BDI. 
Hopelessness: BHS. 
Nature of trial suggests 
participants, clinical 
personnel, and outcome 
assessors not blind to 
allocation. Data on suicides 
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to the accident and 
emergency department. 
service and/or referred for 
psychiatric treatment; 
• Diagnosed with an 
intellectual disability and/or 
organic disorder;  
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; and 
• Residing outside catchment 
area and/or homeless. 
TAU: no information on 
content provided. 
Mental health: Profile of 
Mood States. 
Problem-solving: Personal 
Questionnaire Rapid Scaling 
Technique. 
Suicidal Ideation: BSSI. 
Suicide: unclear how this 
outcome was ascertained. 
 
had to be obtained from 
study authors, suggesting the 
presence of selective 
outcome reporting bias. 
Slee  
(2008) 
Netherlands 40 42 24.7 
(5.5) 
93.9 Admissions to emergency 
departments or mental 
health centers  
• Aged less than 15 or older 
than 35; 
• Diagnosed with an 
intellectual disability and/or 
organic disorder;  
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
• Insufficient language 
ability; and 
• Residing outside catchment 
area and/or homeless. 
CBT-based psychotherapy: 
up to 12 sessions of 
manualized CBT. 
TAU: referral for 
psychotherapy, inpatient 
hospital treatment, and/or 
psychotropic medication as 
required. 
Repetition of SH: self-
report. 
Anxiety: SCL-90, anxiety 
sub-scale. 
Depression: BDI. 
Problem-solving: Coping 
Inventory for Stressful 
Situations. 
Self-esteem: Robson Self-
Concept Questionnaire, 8-
item. 
Suicidal Ideation: SCS. 
Suicide: unclear how this 
outcome was ascertained. 
 
Participants, clinical 
personnel, and outcome 
assessors not blind to 
allocation. Of the 90 
participants randomized, 
eight did not receive the 
intervention. Reasons for this 
were not stated. Analyses 
based on the last observation 
carried forward method 
which may have introduced 
bias. Data on suicides had to 
be obtained from study 
authors, suggesting the 
presence of selective 
outcome reporting bias. 
Stewart  
(2009) 
Australia 23 9 NS 53.1 Admissions to hospital. • Aged less than 18; 
• Diagnosed with an 
intellectual disability and/or 
organic disorder; and 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms. 
 
CBT-based psychotherapy: 
up to 4 weekly sessions of 
manualized individual CBT 
or up to 7 weekly sessions of 
manualized individual 
problem-solving therapy. 
TAU: referral to treatment 
by the local hospital acute 
care team. 
Repetition of SH: hospital 
records 
Hopelessness: BHS. 
Problem-solving: Social 
Problem Solving Inventory-
Revised. 
Treatment satisfaction: 
Client Satisfaction 
Questionnaire, 8 item. 
Suicidal ideation: BSSI. 
Suicide: unclear how this 
outcome was ascertained 
 
 
No information on allocation 
concealment provided. 
Participants, clinical 
personnel, and outcome 
assessors not blind to 
allocation. Correspondence 
with study authors revealed 
10 patients dropped out of 
the TAU arm, 12 from the 
CBT arm, and 11 form the 
PST arm. Data were 
therefore collected for 
treatment completers only; 
analyses were therefore 
based on per protocol 
principles. Data on suicidal 
ideation, hopelessness, 
repetition of self-harm, and 
suicides had to be obtained 
from study authors, 
suggesting the presence of 
significant selective outcome 
reporting bias. 
Tapolaa  
(2010) 
Finland 9 7 33.2 
(NS) 
100.0 Admissions to emergency 
department. 
• Aged less than 18 or older 
than 65; 
• Insufficient language 
ability; and 
CBT-based psychotherapy: 
sessions of acceptance and 
commitment therapy, 
solution-focused brief 
therapy, meditation, 
Repetition of SH: self-
report using the SASII. 
Anxiety: BAI. 
Depression: BDI. 
Nature of trial suggests 
participants and outcome 
assessors not blind to 
allocation. Outcome assessor 
not blind to allocation. Data 
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• Residing outside catchment 
area and/or homeless. 
problem-solving therapy, 
frustration tolerance 
exercises, and identity 
assimilation exercises. 
TAU: psychiatric outpatient 
treatment in the form of 
supportive sessions with a 
mental health nurse in 
addition to pharmacological 
management as required. 
Emotion Regulation: 
DERS. 
Experiential Avoidance: 
AAQ. 
Quality of life: Health-
Related Quality of Life-15D. 
Suicide: unclear how this 
outcome was ascertained. 
 
 
 
only collected on treatment 
completers suggesting 
analyses based on per 
protocol principles. Data on 
repetition of self-harm and 
suicides had to be obtained 
from study authors, 
suggesting the presence of 
significant selective outcome 
reporting bias. 
Torhorst  
(1987) 
Germany 68 73  63.1 Admissions to hospital 
following a suicide 
attempt. 
• Currently receiving 
treatment through another 
service and/or referred for 
psychiatric treatment; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; and 
• Engaged in self-injury only. 
 
Treatment adherence 
intervention: brief inpatient 
admission followed by 
sessions of outpatient 
psychotherapy led by the 
same treating clinician as 
referred to in the hospital. 
Sessions consisted of 
motivational interviewing. 
Different therapist: brief 
inpatient admission followed 
by sessions of outpatient 
psychotherapy led by a 
different treating clinician. 
Sessions also consisted of 
motivational interviewing. 
Repetition of SH: unclear 
how this outcome was 
ascertained. 
Treatment Adherence: 
number of therapy sessions 
attended. 
Suicide: unclear how this 
outcome was ascertained. 
No information on allocation 
concealment provided. 
Nature of trial suggests 
participants, clinical 
personnel, and outcome 
assessors not blind to 
allocation. A greater number 
of participates in the control 
arm dropped out of treatment 
compared to the number in 
the experimental arm. No 
information on whether 
analyses were conducted 
according to intention-to-
treat principles provided. 
Additionally, the authors 
note “[t]here is some 
evidence that patients of the 
experimental group . . . had 
more risk factors for further 
suicidal behaviour than did 
patients of the control 
group. . . despite 
randomization” (p. 56). 
Torhost  
(1988) 
Germany  40 40  Not 
reported. 
Admissions to a general 
hospital following an 
episode of deliberate self-
poisoning who were 
referred to the liaison 
service of the toxicological 
ward. 
• Currently receiving 
treatment through another 
service and/or referred for 
psychiatric treatment; 
• Diagnosed with an 
intellectual disability and/or 
organic disorder; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
• Diagnosed with substance 
dependency and/or misuse; 
and 
• Residing outside catchment 
area and/or homeless. 
Long-term therapy: 1 
session per month over a 
period of 12 months in 
addition to a brief crisis 
intervention session 
delivered within 3 days of 
admission. 
Short-term therapy: 12 
weekly therapy sessions 
delivered over a period of 3 
months in addition to a brief 
crisis intervention session 
delivered within 3 days of 
admission. 
Repetition of SH: self-
report. 
Depression: self-report. 
Mental health: Inpatient 
Multi-Dimensional 
Psychiatric Scale. 
Social Adjustment: SAS. 
Treatment adherence: 
number of therapy sessions 
attended. 
 
No information on allocation 
concealment provided. 
Nature of trial suggests 
participants, clinical 
personnel, and outcome 
assessors not blind to 
allocation. Of the 80 
participants, data on 
50-67% were available at 3 
months, and data on 
97.5%were available at 12 
months. Unclear whether 
analyses were according to 
intention-to-treat principles, 
however. Data on depression 
scores had to be obtained 
from study authors, 
suggesting the presence of 
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significant selective outcome 
reporting bias. 
Turner (2000) USA 12 12  79.2 Admissions to hospital 
following a suicide 
attempt. 
• Currently receiving AOD 
treatment and/or referred for 
AOD treatment; 
• Diagnosed with an 
intellectual disability and/or 
organic disorder; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; and 
• Did not meet criteria for a 
diagnosis of borderline 
personality disorder. 
 
 
Modified DBT: up to 6 
sessions of interpersonal 
skills training, and individual 
DBT modified from the 
original manualized protocol 
to include sessions on 
psychodynamic techniques. 
There were no group-based 
DBT sessions. 
Client-centered therapy: up 
to 6 sessions of interpersonal 
skills training and client-
centered therapy based on 
Carkhuff’s emphatic 
understanding model. 
Treatment also included a 
no-suicide contract. 
Repetition of SH: self-
report. 
Anxiety: BAI. 
Depression: HRSD and 
BDI. 
Mental health: BPRS. 
Problem-solving: Target 
Behavior Ratings. 
Suicidal ideation: BSSI. 
No information on allocation 
concealment provided. 
Nature of trial suggests 
participants and clinical 
personnel not blind to 
allocation. 
Tyrer  
(2003) 
UK 239 241 32.0 
(11.0) 
67.9 Admissions to hospital. • Currently receiving 
treatment through another 
service and/or referred for 
psychiatric treatment; 
• Diagnosed with bipolar 
disorder; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; and 
• Diagnosed with substance 
dependency and/or misuse. 
 
CBT-based psychotherapy: 
sessions of manual-assisted 
CBT including sessions on 
cognitive techniques for 
emotion regulation, negative 
thinking management, and 
the development of relapse 
prevention strategies. 
Sessions on crisis skills 
problem-solving therapy 
were also provided. 
TAU: referral for psychiatric 
assessment, psychiatric 
outpatient treatment, 
occasional day-patient care, 
partial hospitalization, 
general practitioner 
management, or a 
combination of these. 
Repetition of SH: self-
report supplemented by 
medical records. 
Anxiety: HADS and BAI. 
Depression: HADS and 
Montgomery-Åsberg 
Depression Rating Scale 
(MADRS). 
Quality of life: EuroQoL. 
Personality: Quick 
Personality Assessment 
Schedule (PAS-Q). 
Social Functioning: GAF. 
Suicide: Coroner’s records. 
 
 
Nature of trial suggests 
participants, clinical 
personnel, and outcome 
assessors not blind to 
allocation. Of the 480 
participants randomized, 
study authors could not 
obtain 12-month data for 78 
(16.2%) participants for the 
following reasons: i) could 
not be traced (n = 27); ii) 
refused follow-up assessment 
(n = 19); iii) did not attend 
follow-up assessment (n = 
9); iv) died (n = 8); v) 
withdrew (n = 4); vi) other 
reasons (n = 11). No 
information on whether 
analyses were based on 
intention-to-treat principles 
was provided, however. 
Vaiva  
(2006) 
France 293 312  72.9 Presentations to general 
hospitals following an 
intentional drug overdose. 
• Aged less than 18 or older 
than 65; 
• Diagnosed with substance 
dependency and/or misuse; 
• Engaged in self-injury only; 
• Not registered with a GP; 
• No telephone connection; 
and 
• Residing outside catchment 
area and/or homeless. 
 
Telephone contact: at least 
one telephone call to 
encourage participants to 
adhere to their discharge 
treatment plan. 
TAU: referral to the general 
practitioner. 
Repetition of SH: self-
report supplemented by 
hospital records. 
Treatment use: self-report 
supplemented by hospital 
records. 
Suicide: collateral informant 
report supplemented by 
hospital, medical, or 
mortality records.  
 
Nature of trial suggests 
participants and clinical 
personnel not blind to 
allocation. Of the 605 
participants, 89 (14.7%) did 
not complete the  
intervention, and 121 
(20.0%) were lost to follow-
up at 13 
months for the following 
reasons: i) died; ii) unstated 
reasons. No information on 
whether analyses were based 
on intention-to-treat 
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principles was provided, 
however. 
Van Der Saande 
(1997) 
Netherlands 140 134  65.7 Admissions to hospital 
following a suicide 
attempt. 
• Aged less than 15; 
• Currently receiving 
treatment through another 
service and/or referred for 
psychiatric treatment; 
• Diagnosed with substance 
dependency and/or misuse; 
• Engaged in habitual self-
cutting only; 
• Insufficient language 
ability; 
• Residing outside catchment 
area and/or homeless; and 
• Residing in prison and/or 
custodial environment. 
Brief inpatient admission: 
inpatient admission for a 
period of between 1-4 days. 
Participants then offered 
referral to outpatient 
problem-solving therapy. 
TAU: inpatient psychiatric 
treatment (25.0%), or referral 
to outpatient psychiatric 
services (75.0%). 
Repetition of SH: hospital 
records. 
Anxiety: SCL-90. 
Depression: SCL-90. 
Hopelessness: BHI. 
Mental health: SCL-90. 
Suicide: collateral informant 
report supplemented by 
mortality records. 
Treatment use: self-report 
supplemented with collateral 
informant report. 
 
Nature of trial suggests 
participants not blind to 
allocation. 
Van Heeringen Belgium 258 258  56.6 Admissions to the accident 
and emergency department 
following a suicide 
attempt. 
• Aged less than 15; 
• Residing outside catchment 
area and/or homeless; and 
• Residing in prison and/or 
custodial environment. 
 
Compliance enhancement: 
series of home visits to 
participants to encourage 
them to keep scheduled 
outpatient psychiatric 
treatment appointments. 
TAU: referral for outpatient 
psychiatric treatment. Non-
compliant participants did 
not receive home visits.  
Repetition of SH: self-
report supplemented by 
collateral informant report. 
Suicide: mortality register. 
Treatment use: self-report 
supplemented by collateral 
informant report.   
Random sequence generation 
may have led to selection 
bias as an open numbers 
table was used. Treatment 
allocation also could not be 
concealed as a consequence. 
Of the 516 participants, 125 
(24.2%) were lost to follow-
up. Reasons 
given for dropouts included: 
i) refused follow-up 
assessment (n = 97); 
ii)moved from catchment 
area without leaving a 
forwarding address (n = 22); 
iii) death following a somatic 
illness (n = 2); iv) admitted 
to hospital with a terminal 
illness (n = 2); v) 
imprisoned (n = 2). No 
information on whether 
analyses were based on 
intention-to-treat principles 
was provided, however. 
Waterhouse 
(1990) 
UK 38  39 Not 
reported. 
Admissions to the accident 
and emergency department 
following an episode of 
self-harm. 
• Aged less than 16; 
• Currently receiving 
treatment through another 
service and/or referred for 
psychiatric treatment; 
• Engaged in self-injury only; 
and 
• Residing outside catchment 
area and/or homeless. 
 
General hospital 
admission: admission to a 
general hospital ward 
without further referral to 
psychiatric, social, or other 
services. 
Discharge: participants 
discharged from hospital as 
soon as medically stable. 
Repetition of SH: hospital 
records. 
Anxiety: Psychiatric Status 
Schedule, sub-scale. 
Depression: Psychiatric 
Status Schedule, sub-scale. 
Hopelessness: BHI. 
Functioning: Psychiatric 
Status Schedule. 
Social Functioning: Social 
Behavior Assessment 
Schedule. 
Nature of trial suggests 
participants and clinical 
personnel not blind to 
allocation. Outcome 
assessors not blind to 
treatment allocation. 
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Treatment use: General 
Practitioner Questionnaire, 
supplemented with medical 
records. 
Wei  
(2013) 
China 162 77 31.8 
(12.9) 
76.1 Admissions to emergency 
department. 
• Aged less than 15; 
• Diagnosed with an 
intellectual disability and/or 
organic disorder; 
• Insufficient language 
ability; and 
• Without at least two contact 
persons (to facilitate 
attendance at follow-up 
appointments). 
 
CBT-based psychotherapy: 
sessions of cognitive therapy. 
Telephone contact: 
psychological support via 
telephone. 
TAU: no intervention.  
Repetition of SH: self-
report. 
Depression: HDRS. 
Quality of life: idiosyncratic 
scale. 
Suicidal ideation: BSSI. 
Suicide: collateral informant 
report. 
Treatment use: self-report. 
Nature of trial suggests 
participants, clinical 
personnel, and outcome 
assessors not blind to 
allocation. 
Weinberg 
(2006) 
USA 15 15 28.2 
(8.2) 
100.0 Community referrals. • Aged less than 18 or older 
than 40; 
• Diagnosed with bipolar 
disorder; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
• Diagnosed with substance 
dependency and/or misuse; 
• Did not meet criteria for a 
diagnosis of borderline 
personality disorder; 
• Males; and 
• Suicide risk 
CBT-based psychotherapy: 
up to 6 sessions of 
manualized cognitive 
therapy, crisis skills training, 
problem-solving skills 
training, emotion regulation, 
negative thinking 
management, and relapse 
prevention training. 
TAU: no information 
provided. 
Repetition of SH: self-
report using the SASII. 
Suicidal ideation: Suicide 
Behaviors Questionnaire, 
ideation sub-scale. 
Treatment use: Treatment 
Utilization Intervention, 
Follow-Along Version. 
Suicide: unclear how this 
outcome was ascertained. 
 
Nature of trial suggests 
participants, clinical 
personnel, and outcome 
assessors not blind to 
allocation. Data on suicides 
had to be obtained from 
study authors, suggesting the 
presence of significant 
selective outcome reporting 
bias. 
Welu (1977) USA 63 57  Not 
reported. 
Admissions to the accident 
and emergency department 
following an episode of 
self-harm. 
• Aged less than 16; 
• Residing outside catchment 
area and/or homeless; and 
• Residing in other 
institutional environments. 
 
Outreach: weekly/bi-weekly 
community mental health 
team contact. 
TAU: psychiatric 
consultation on request of the 
treating physician and 
referral for a next day 
appointment at the 
community mental health 
center. 
Repetition of SH: hospital 
records. 
Alcohol use: self-report. 
Drug use: self-report. 
Treatment use: number of 
therapy sessions attended. 
No information on allocation 
concealment provided. 
Nature of trial suggests 
participants, clinical 
personnel, and outcome 
assessors not blind to 
allocation. Of the 120 
participants, 6 (9.5%) in the 
experimental arm and 26 
(45.6%) in the control arm 
were lost to follow-up for 
unstated reasons. No 
information on whether 
analyses were based on 
intention-to-treat principles 
was provided, however. 
CHILDREN & ADOLESCENTS 
 
        
Cooney  
(2010) 
New Zealand 14 15  75.9  • Aged less than 13 or older 
than 19; 
• Diagnosed with an 
intellectual disability and/or 
organic disorder; 
DBT-A: comprising weekly 
individual therapy sessions 
(50-60 minutes), weekly 
group skills training (110 
minutes), and family therapy 
Repetition of SH: self-
report using the SASII and 
according to hospital records. 
Alcohol and/or drug use: 
Substances And Choices 
Scale (SACS). 
Participants and clinical 
personnel not blind to 
treatment allocation. 
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• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
• Insufficient language 
ability; 
• No history of self-harm 
prior to the index episode 
(unclear how this was 
ascertained); and 
• No adult caregiver willing 
and/or able to attend family 
therapy sessions. 
and telephone counselling as 
required. 
TAU: comprising individual 
and family sessions provided 
by a multidisciplinary 
treatment team, medication 
management, and hospital or 
respite care as required. 
Emotion regulation: DERS. 
Hopelessness: Reasons for 
Living Inventory for 
Adolescents (reverse scored). 
Suicidal Ideation: BSSI. 
Treatment use: number of 
therapy sessions attended. 
Cotgrove  
(1995) 
UK 47 58  84.8  • Aged less than 16; and 
• Residing outside catchment 
area and/or homeless. 
Emergency card: 
comprising one card that 
could be used, on demand, to 
allow re-admission to a 
pediatric ward at the local 
hospital at times of distress. 
TAU: referral for standard 
follow-up, including 
treatment from a specialist 
clinic or child psychiatry 
department as required. 
Repetition of SH: hospital 
records. 
Treatment use: collateral 
informant report. 
An open numbers table was 
used to generate the random 
sequence, leading to possible 
bias in the random sequence 
generation and allocation 
concealment. Additionally, 
the nature of the trial 
suggests participants and 
outcome assessors not blind 
to allocation. Also, unclear if 
outcome assessors were 
blind to treatment allocation, 
Five participants in one 
center either received their 
emergency card after a delay 
of several weeks, or not at 
all. It is unclear whether and 
how data from these 
participants was analyzed. 
Finally, the authors claim 
this intervention as effective 
even when comparison of 
repetition rates (the primary 
outcome) was not significant.  
Donaldson 
(2005) 
USA 21 18  82.0 Patients presenting to a 
general pediatric 
emergency department or 
inpatient unit of an 
affiliated child psychiatric 
hospital after a suicide 
attempt. 
• Aged less than 12 or older 
than 17; 
• Diagnosed with an 
intellectual disability and/or 
organic disorder; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; and 
• Insufficient language 
ability. 
Skills-based, problem-
solving treatment: up to 12 
sessions of problem-solving 
and affective management 
therapy, including cognitive 
restructuring, and relaxation. 
Supportive relationship 
therapy: up to 12 sessions of 
unstructured therapy, 
including exploratory 
questioning, encouraging 
affect, connecting affect to 
events, and reviewing 
changes obtained by therapy. 
Participants were not taught 
any specific therapeutic 
techniques.  
Repetition of SH: self-
report and/or collateral 
informant report. 
Anger: STAXI. 
Depression: Centre for 
Epidemiologic Studies, 
Depression (CES-D) scale. 
Problem-solving: Social 
Problem Solving Inventory-
Revised, and the MEPS. 
Suicidal ideation: SIQ. 
Suicide: collateral informant 
report. 
Not information on 
allocation concealment 
provided. Nature of trial 
suggests participants not 
blind to treatment allocation. 
Additionally, as the same 
therapists provided both the 
intervention and control 
treatments, clinical personnel 
blinding could not be 
achieved. Intervention 
contamination also may have 
occurred. No information on 
outcome assessor blinding 
provided. Data on suicides 
had to be obtained following 
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correspondence with study 
authors.  
Green  
(2011) 
UK 183 183  88.5 Patients presenting to local 
child and adolescent 
services with a history of 
at least two episodes of 
self-harm within the 
previous 12 months. 
• Aged less than 12 or older 
than 16 years, 11 months; 
• Diagnosed with anorexia 
nervosa (and with severe 
low body mass); 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
• Enrolled in a school for 
students with intellectual 
disabilities; 
• Insufficient language 
ability; 
• No history of self-harm 
prior to the index episode 
(unclear how this was 
ascertained); and 
• Residing in prison and/or 
custodial environment. 
Group-based 
psychotherapy: Developed 
by Wood (2001), this is a 
manualized developmental 
psychotherapy program 
delivered in a group format. 
Sessions involve elements of 
CBT, DBT, and group 
psychotherapy. 
TAU: comprising any form 
of therapy with the exception 
of any group-based 
intervention, recommended 
by the adolescents’ child and 
adolescent mental health 
service team. 
Repetition of SH: self-
report using a standardized 
interview. 
Depression: Mood and 
Feelings Questionnaire 
(MFQ). 
Functioning: Health of the 
Nation Outcome Scales for 
Children and Adolescents 
(HoNOSCA). 
Suicidal Ideation: SIQ. 
Suicide: medical records. 
Treatment use: medical and 
social services records. 
 
Participants and clinical 
personnel not blind to 
treatment allocation. Not all 
participants included in 
analyses for primary and 
secondary outcomes, 
although the authors claim to 
have used an intention-to-
treat approach. Attrition bias 
therefore cannot be ruled out. 
Harrington 
(1998) 
UK 85 77  89.5 Patients referred to mental 
health teams from one of 
four hospitals. 
• Aged less than 16; 
• Currently receiving 
treatment through another 
service and/or referred for 
psychiatric treatment; 
• Diagnosed with an 
intellectual disability and/or 
organic disorder; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
• Engaged in self-injury only; 
• No adult caregiver willing 
and/or able to attend family 
therapy sessions; and 
• Suicide risk. 
Home-based family 
therapy: comprising a 
manualized family therapy 
intervention involving one 
assessment session and up to 
four home visits. 
TAU: no details provided. 
Repetition of SH: self-
report using a standardized 
interview. 
Family Functioning: Family 
Assessment Device. 
Hopelessness: Hopelessness 
Questionnaire. 
Problem-solving: SPSI 
generation of alternative 
solutions subscale. 
Suicidal Ideation: SIQ. 
Suicide: unclear how this 
outcome was ascertained. 
 
 
Nature of trial suggests 
participants not blind to 
allocation. Additionally, 
clinical personnel not blind 
to treatment allocation. 
Authors’ state analyses 
conducted according to 
intention-to-treat principles. 
However, outcome 
assessment were conducted 
with 154/162 (95.1%) cases 
to two months, and with 
149/162 (92.0%) cases at six 
months. 
Hazell  
(2009) 
Australia 35 37  90.3 Patients referred to a child 
and adolescent mental 
health service who had 
reported at least two 
episodes of SH in the past 
year, with one of these in 
the past three months. 
• Aged less than 12 or older 
than 16; 
• Currently receiving 
treatment through another 
service and/or referred for 
psychiatric treatment; 
• Diagnosed with an 
intellectual disability and/or 
organic disorder; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
• Diagnosed with substance 
dependency and/or misuse; 
Group-based 
psychotherapy: Developed 
by Wood (2001), this is a 
manualized developmental 
psychotherapy program 
delivered in a group format. 
Sessions involve elements of 
CBT, DBT, and group 
psychotherapy. 
TAU: could involve 
individual counselling, 
family therapy sessions, 
medication assessment and 
review, and/or other care co-
ordination. 
Repetition of SH: self-
report using a standardized 
interview. 
Alcohol and/or drug use: 
K-SADS scores. 
Depression: MFQ and the 
Schedule for Affective 
Disorders and Schizophrenia 
for School-Age Children (K-
SADS). 
Functioning: Children’s 
Global Assessment Scale, 
Strengths and Difficulties 
Questionnaire, and the 
HoNOSCA. 
Suicidal Ideation: SIQ. 
Participants and clinical 
personnel not blind to 
treatment allocation. Data 
analyzed according to 
intention-to-treat principles, 
however, method used last 
observation carried forward 
which may introduce bias. 
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• No history of self-harm 
prior to the index episode 
(unclear how this was 
ascertained); and 
• Suicide risk. 
Suicide: medical records. 
Treatment use: medical 
records. 
 
Mehlum  
(2014) 
Norway 39 38  88.3 Patients referred to a child 
and adolescent mental 
health service who 
reported at least two 
episodes of self-harm in 
the past year, with one of 
these in the past 16 weeks. 
• Aged less than 12 or older 
than 18; 
• Diagnosed with bipolar 
disorder; 
• Diagnosed with an 
intellectual disability and/or 
organic disorder; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
• Did not meet criteria for a 
diagnosis of borderline 
personality disorder and/or 
borderline traits; and 
• No history of self-harm 
prior to the index episode 
(unclear how this was 
ascertained). 
DBT-A: comprising weekly 
individual therapy sessions, 
weekly group skills training, 
weekly multifamily skills 
training, weekly family 
therapy, and telephone 
counselling as required. 
EUC: no less than one 
weekly individual therapy 
session. 
Repetition of SH: self-
report and hospital records. 
Depression: Short Mood and 
Feelings Questionnaire 
(SMFQ) and MADRS. 
Hopelessness: BHS. 
Personality disorder: 
Borderline Symptom List, 23 
item. 
Suicidal Ideation: SIQ. 
Suicide: unclear how this 
outcome was ascertained. 
 
 
Participants and clinical 
personnel not blind to 
treatment allocation. 
Ougrin  
(2011) 
UK 35 35  80.0 Patients admitted to 
emergency departments 
following an episode of 
self-harm. 
• Aged less than 12 or older 
than 18; 
• Currently receiving 
treatment through another 
service and/or referred for 
psychiatric treatment; 
• Diagnosed with an 
intellectual disability and/or 
organic disorder; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
• Diagnosed with substance 
dependency and/or misuse; 
• Insufficient language 
ability; 
• Suicide risk; and 
• Violence risk. 
 
Therapeutic assessment: 
manualized assessment 
involving standard 
psychosocial history and 
suicide risk assessment, 
identification of reciprocal 
roles, core pain, and 
maladaptive behaviors based 
on a cognitive analytic 
therapy paradigm. 
Participants also identify 
their target problems, think 
of ways to change these 
problems, motivations for 
change, and explore 
alternative coping strategies. 
The session concludes with 
writing of an understanding 
letter summarizing these 
steps which is sent to 
parents. 
TAU: standard psychosocial 
history and suicide risk 
assessment based on NICE 
principles. 
Repetition of SH: hospital 
records. 
Functioning: Children’s 
Global Assessment Scale, 
and Strengths and 
Difficulties Questionnaire. 
Treatment use: medical 
records supplemented by 
collateral informant report. 
Suicide: unclear how this 
outcome was ascertained. 
 
 
 
Participants and clinical 
personnel not blind to 
treatment allocation. Data 
analyzed according to 
intention-to-treat principles, 
however, method used last 
observation carried forward 
which may introduce bias. 
Rossouw  
(2012) 
UK 40 40  85.0 Patients presenting to 
community health services 
or acute hospital accident 
and emergency 
• Aged less than 12 or older 
than 17; 
• Currently receiving 
treatment through another 
Mentalization-based 
therapy: manualized 
psychodynamic 
psychotherapy involving 
sessions for both the 
Repetition of SH: self-
report using the Risk-Taking 
and Self-Harm Inventory and 
the Childhood Interview for 
Nature of the study suggests 
clinical personnel not blind 
to treatment allocation. Some 
participants in the control 
group (19.0%) receive 
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departments following an 
episode of self-harm. 
service and/or referred for 
psychiatric treatment; 
• Diagnosed with an eating 
disorder; 
• Diagnosed with an 
intellectual disability and/or 
organic disorder; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; and 
• Diagnosed with substance 
dependency and/or misuse. 
 
adolescent and his/her 
family. 
TAU: could involve 
individual therapy (28.0%), 
counselling (38.0%), 
supportive therapy (24.0%), 
CBT (19.0%), 
psychodynamic 
psychotherapy (19.0%), 
combination of individual 
and family therapy (25.0%), 
or a psychiatric review alone 
(27.5%). 
DSM-IV Borderline 
Personality Disorder. 
Attachment: Experience of 
Close Relationships 
Inventory. 
Depression: MFQ. 
Personality Disorder: 
Childhood Interview for 
DSM-IV Borderline 
Personality Disorder. 
Mentalization: How I Feel 
Questionnaire. 
Risk-taking: Risk-Taking 
and Self-Harm Inventory. 
Suicide: unclear how this 
outcome was ascertained. 
sessions of psychodynamic 
psychotherapy similar to that 
offered within the 
intervention condition. 
Spirito  
(2002) 
USA 36 40  94.1 Patients presenting to 
hospital following a 
suicide attempt. 
• Aged less than 12 or older 
than 18; and 
• Residing outside catchment 
area and/or homeless. 
Compliance enhancement: 
one-hour session reviewing 
expectations for outpatient 
treatment, addressing the 
factors likely to impede 
attendance, and addressing 
treatment misconceptions. 
Verbal contract between 
adolescent, parents, and staff 
to attend all treatment 
sessions. Participants also 
contacted by telephone at 1, 
2, 4, and 8 weeks post-
discharge to review 
compliance with treatment. 
Standard disposition 
planning: comprising 
treatment based on 
judgement of treating 
psychiatrist. Some 
participants had a brief 
inpatient stay prior to 
receiving outpatient care, 
whilst the remainder received 
outpatient care at a local 
mental health center. 
Repetition of SH: self-
report. 
Anger: STAXI.  
Depression: CES-D. 
Hopelessness: Hopelessness 
Scale for Children. 
Family Functioning: 
McMaster Family 
Assessment Device. 
Treatment barriers: 
Barriers to Service 
Questionnaire, Family 
Barriers according to an 
idiosyncratic scale, and 
Service Barriers according to 
an idiosyncratic scale. 
Treatment use: self-report 
supplemented by collateral 
informant report.  
Suicide Intent: SIS. 
Suicide: unclear how this 
outcome was ascertained. 
 
No information on allocation 
concealment provided. 
Nature of the study suggests 
participants and clinical 
personnel not blind to 
treatment allocation. No 
information on outcome 
assessor blinding provided. 
Data on suicides had to be 
requested from study 
authors, suggesting possible 
selective reporting bias. 
Wood (2001) UK 32 31  77.8 Patients referred to child 
and adolescent mental 
health services following 
an episode of self-harm. 
• Aged less than 12 or older 
than 16; 
• Diagnosed with an 
intellectual disability and/or 
organic disorder; 
• Diagnosed with psychosis 
and/or experiences 
psychotic symptoms; 
• Residing in prison and/or 
custodial environment; and 
• Suicide risk. 
Group-based 
psychotherapy: a 
manualized developmental 
psychotherapy program 
delivered in a group format. 
Sessions involve elements of 
CBT, DBT, and group 
psychotherapy. Treatment 
comprises a one-off initial 
assessment, followed by 6 
acute group-therapy sessions, 
and weekly therapy sessions 
Repetition of SH: self-
report using a standardized 
interview. 
Depression: SMFQ and K-
SADS. 
Functioning: HoNOSCA. 
Suicidal ideation: SIQ. 
Suicide: unclear how this 
outcome was ascertained. 
 
 
Nature of trial suggests 
participants and clinical 
personnel not blind to 
allocation. Data on suicides 
had to be requested from 
study authors, suggesting 
possible selective reporting 
bias. 
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continuing until the young 
person feels ready to leave 
the intervention. 
TAU: could comprise non-
specific counselling, family 
therapy sessions, and 
psychotropic medication as 
required. 
Table Notes: AOD: alcohol and other drug; CBT: cognitive behavioral therapy; DBT: dialectical behavior therapy; DBT-A: dialectical behavior therapy for adolescents; SH: 
self-harm; TAU: Treatment as usual; UK: United Kingdom; USA: United States of America. 
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Table 2. Power calculations for trials to assess impact of cognitive behavioral-based psychotherapy in adults on repetition of self-harm and suicide over a 12-month follow-
up period. 
 
Outcome 
Event rate (%) Sample size  
(per arm) Usual Care Group 
Intervention 
Group 
Repetition of self-harm 16.3 3.3 1,862 
Suicide 1.6 0.05 8,757 
Note: Based on actual rates of repetition of self-harm and suicide over a 12 
month follow-up period for cognitive behavioral-based psychotherapy in the 
recent Cochrane review of psychological interventions for adults (Hawton et 
al., 2016b), with alpha set at 5% and power at 80%. 
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